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6                                                                      Chapter 1 Introduction 
 
1.1 The order Herpesvirales 
The Herpesviridae are a large family of DNA viruses which have as their natural 
hosts mammals, birds, reptiles, bony fishes, frogs and molluscs (Davison, 2010). All 
members of the Herpesviridae are considered to have evolved from a common 
herpesvirus ancestor which originated 400 million years ago (Davison, 2007). During 
this evolution, the genomes of these herpesviruses became quite different in terms of 
nucleotide sequence, gene content, and genomic arrangement (McGeoch et al., 2000). 
Up till now, there are nine known human herpesviruses and a large number of animal 
herpesviruses. Phylogenetic studies have subdivided Herpesviridae into three distinct 
subfamilies: alpha-, beta- and gamma-herpesviruses (Leroy et al., 2016). 
 
Among those subfamilies, members of the Alphaherpesvirinae are characterized by 
their short replication cycle, fast destruction of infected cells, induction of lifelong 
latency, primary in neurons, and a broad host cell range (Remeijer et al., 2004). There 
are four genera in the Alphaherpesvirinae subfamily: Simplexvirus, Varicellovirus, 
Mardivirus and Iltovirus (Arvin and Abendroth, 2007). Human herpes simplex virus 1 
(HSV1) and 2 (HSV-2) belong to the Simplexvirus genus. Known species of the 
Varicellovirus genus are bovine herpesvirus 1 (BoHV1), equine herpesvirus 1 (EHV1), 
suid herpesvirus 1 (SuHV1, PrV), feline herpesvirus 1 (FeHV1), canine herpesvirus 1 
(CaHV1) and human herpesvirus varicella-zoster virus (VZV). Table 1 provides an 
overview of members of the Varicellovirus genus. VZV is the prototype species in the 
genus, and PrV is also a well-studied varicellovirus. 
 
Betaherpesvirinae contain four genera: Cytomegalovirus, Muromegalovirus, 
Roseolovirus and Proboscivirus. In this family, the virus’ host range is quite restricted. 
Betaherpesviruses are characterized by a long replication cycle, which is different 
from alphaherpesviruses (Roizman and Baines, 1991). Gammaherpesvirinae prefer to 
enter the latency program instead of leading to a productive replication. Members of 
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this subfamily are subdivided into four genera: Lymphocryptovirus, Rhadinovirus, 
Macavirus and Percavirus (Davison et al., 2009).  
 
Table 1. Members of the Varicellovirus genus  
Name Acronym Common name Host 
Bovine herpesvirus 1 BoHV1 Infectious bovine rhinotracheitis virus Cattle 
Bovine herpesvirus 5 BoHV5 Bovine encephalitis herpesvirus Cattle 
Bubaline herpesvirus 1 BuHV1 Water buffalo herpesvirus Buffalo 
Canine herpesvirus 1 CaHV1 Canine herpesvirus Dog 
Caprine herpesvirus 1 CpHV1 Goat herpesvirus Goat 
Cercopithecine herpesvirus 9 CeHV9 Simian varicella virus Monkey 
Cervid herpesvirus 1 CvHV1 Red deer herpesvirus Deer 
Cervid herpesvirus 2 CvHV2 Reindeer herpesvirus Deer 
Equine herpesvirus 1 EHV1 Equine abortion virus Horse 
Equine herpesvirus 3 EHV3 Equine coital exanthema virus Horse 
Equine herpesvirus 4 EHV4 Equine rhinopneumonitis virus Horse 
Equine herpesvirus 8 EHV8 Asinine herpesvirus 3 Horse 
Feline herpesvirus 1 FeHV1 Feline rhinotracheitis virus Cats 
Human herpesvirus 3 HHV3 Varicella-zoster virus Human 
Phocine herpesvirus 1 PhoHV1 Harbour seal herpesvirus Seal 
Suid herpesvirus 1 SuHV1/PrV Pseudorabies virus Pig 
 
1.1.1 Virion structure of alphaherpesviruses  
Mature (fully assembled) herpesvirus particles contain four morphologically distinct 
elements: the genome, capsid, tegument, and envelope. The general architecture of a 
herpesvirus particle is given in Figure 1. Mature (fully assembled) alphaherpesvirus 
particles have a diameter of about 200 nm. Variation is caused by the variable 
dimension of the tegument. The core contains a double stranded DNA genome, which 
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is packaged into the capsid. The tegument is a poorly defined layer of proteinaceous 
material between the capsid and envelope. The envelope is a lipid bilayer containing a 









Figure 1. Morphology of alphaherpesviruses. Mature (fully assembled) herpesvirus particles 
contain four morphologically distinct elements: the genome, capsid, tegument and envelope. 
 
Alphaherpesvirus genomes are linear and double stranded. Circularization of DNA 
occurs immediately after the viral DNA becomes released from the capsid into the 
nucleus of the infected cell (Strang and Stow, 2005). The genome length may differ 
between alphaherpesviruses (Parsons et al., 2015). These differences are mainly due 
to the variable copy numbers of terminal and internal repeat sequences (Roizman, 
1979). Alphaherpesvirus genomes have two unique regions, intermitted and flanked 
by reiterated DNA sequences (Ziemann et al., 1998). For instance, PrV has a classical 
arrangement of varicelloviruses with one unique long (UL), one internal repeat (IR), 
one unique short (US) and one terminal repeat (TR) sequence. In the past, 70 different 
genes of PrV were identified (Pomeranz et al., 2005). Among these genes, 11 encode 
viral surface glycoproteins that are involved in virus attachment, cell penetration and 
egress, cell-to-cell spread, pathogenicity and virulence (Table 2). These and most 
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Table 2. Alphaherpesviruses glycoprotein functions  
Name Gene Proposed function(s)  
gB  UL27 Viral entry (fusion); cell-cell spread 
gC UL44 Viral entry (virion attachment); binds to heparan sulfate  
gD US6 Viral entry (cellular receptor binding protein) 
gE US8 Cell-cell spread; complexed with gI; C-terminus interacts with UL49; 
protein sorting in axons  
gG US4 Unknown  
gH UL22 Viral entry (fusion); cell-cell spread; complexed with gL  
gI US7 Cell-cell spread; complexed with gE  
gK UL53 Viral egress (secondary envelopment); gK/UL20 inhibit glycoprotein- 
mediated membrane fusion 
gL UL1 Viral entry (fusion); cell-cell spread; membrane anchored via complex with 
gH  
gM UL10 Inhibits glycoprotein-mediated membrane fusion; C terminus interacts with 
tegument protein UL49; complexed with gN  
gN UL49.5 Immune evasion (TAP inhibitor); complexed with Gm 
 
1.1.2 Phylogenetic relationship between alphaherpesviruses  
Phylogenetic analysis of herpesviruses is well described nowadays. These studies 
have generated a tree that is well resolved and robust by primarily concatenated 
alignments of amino acid sequences from a set of up to eight core genes (McGeoch et 
al., 2006). Within these analyses, it is well know that PrV is found to be the closest 
relative of BoHV1 and 5 (Ros and Belak, 1999). The tree's structure allowed the 
addition of data for more species as they became available. In 2016, a full genome 
sequence of CaHV1 was reported and a phylogenetic analysis was performed. The 
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analysis was based on UL30 genes of CaHV1 and some other related herpesviruses 
(Figure 2). It showed that CaHV1 is most related to FeHV1 and then to equine 
herpesviruses (Papageorgiou et al., 2016).  
 
 
Figure 2. Phylogenetic tree of varicellovirus DNA polymerases (based on UL30) 
(Papageorgiou et al., 2016). The tree was rooted on HSV1, which is a member of genus 
Simplexvirus. Bootstrap values are indicated at nodes as fractions. The scale bar indicates 
substitutions per amino acid residue. 
 
1.2 Replication cycle of alphaherpesviruses 
An overview of the alphaherpesvirus replication cycle is described in Figure 3. 
 
1.2.1 Entry  
The replication cycle of an alphaherpesvirus starts with the binding of the virus to a 
cellular receptor on a permissive cell. Some cellular surface receptors and viral 
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glycoproteins have been associated with this process. gD is the main HSV 
receptor-binding protein. It binds three classes of receptors: herpes virus entry 
mediator (HVEM), a member of the TNF receptor family; nectin-1 and nectin-2, cell 
adhesion molecules of the immunoglobulin superfamily; and 3-O-sulfated heparan 
sulfate (Connolly et al., 2011, Spear et al., 2000). In addition to gD, gB can bind to 
paired immunoglobulin-like type 2 receptor alpha (PILRα) and this interaction can 
trigger viral fusion in the presence of gD (Connolly et al., 2011). Besides, two 
recently-identified receptors also have been shown to interact with gB and trigger 
HSV-1 entry: non-muscle myosin heavy chain IIA (NMHC-IIA) and 
myelin-associated glycoprotein (MAG), a protein expressed on neural tissues 
(Connolly et al., 2011). Human nectin-1 and nectin-2, but not HVEM or 3-O-sulfated 
heparan sulfate, could mediate entry of PrV into CHO cells, with nectin-1 being the 
most effective (Pomeranz et al., 2005; Spear et al., 2000). Alphaherpesvirus entry into 
cells requires a multipartite fusion apparatus made of gB, gD and gH/gL 
(Krummenacher et al., 2013). Generally, the virus attaches to cell membranes by the 
interaction of gC with heparan sulfate proteoglycans (Rue and Ryan, 2003). Next, gD 
contacts with a cellular receptor to attain a stable binding (Krummenacher et al., 
2013). 
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Figure 3. Productive replication cycle of PrV (Pomeranz et al., 2005). 1. Entry starts with 
attachment or binding of the virus particle to the cell surface: interaction between gC in the 
virion envelope and heparan sulfate on the surface of the cell. 2. The next steps of entry 
require gD, gB, gH, and gL. 3. The capsid and tegument proteins are released into the cell. 4. 
The capsid and tightly bound inner tegument proteins are transported along microtubules to 
the cell nucleus. 5. The VP16 tegument protein localizes to the nucleus independent of the 
capsid and transactivates cellular RNA polymerase II transcription of the only 
immediate-early protein of PRV, the HSV ICP4 homolog IE180. 6. The newly produced IE180 
protein is transported back to the nucleus. 7. There, it transactivates RNA polymerase II 
transcription of the early genes. 8. Early proteins fall into two main categories. 9. Seven of 
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these proteins (UL5, UL8, UL9/OBP, UL29/ssDNABP, UL30/DNA Pol, UL42/Pap, and UL52) 
(shown in blue) are essential for replication of the viral DNA. 10. The second category 
comprises three proteins (EP0, US1, and UL54) thought to act as transactivators of 
transcription. 11. Onset of DNA synthesis signals the start of the late stage of the PRV 
replication cycle and synthesis of true late proteins. 12. The capsid proteins are transported 
to the nucleus. 13. The mature capsid is composed of five proteins (UL19/VP5, UL18/VP23, 
UL25, UL38, and UL35). The product of the UL6 gene acts as a portal for insertion of the 
genomic DNA. 14. The fully assembled nucleocapsid buds out of the nucleus, temporarily 
entering the perinuclear space. This process involves the products of the UL31 and UL34 
genes along with the US3 kinase. 15 and 16. The nucleocapsid (15) loses its primary envelope 
and (16) gains its final envelope by associating with tegument and envelope proteins and 
budding into the trans-Golgi apparatus. 17. The mature virus is brought to the cell surface 
within a sorting compartment/vesicle derived from the envelopment compartment. 
 
1.2.2 Replication and transcription  
Upon nuclear entry, the linear genome circularizes. Afterwards, transcription starts 
immediately and gene expression happens in a cascade manner. Alphaherpesvirus 
genes belong to three categories that are sequentially transcribed: immediate-early 
(IE), early (E) and late (L) genes (Nicoll et al., 2012). After entry in the nucleus, IE 
genes are transcribed by using the host nuclear machinery (Nauwynck et al., 2007). 
For PrV, the only IE gene is IE 180. IE180 protein, expressed in the cytoplasm, is 
transported back to the nucleus (Pomeranz et al., 2005). The E gene products are 
formed which mainly play a role in nucleotide metabolism and DNA synthesis. L 
genes mainly encode structural proteins, such as capsid, tegument and envelope 
proteins (Lehman and Boehmer, 1999). 
 
1.2.3 Assembly and release 
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In the nucleus, capsid precursors assemble by the interaction of pUL19 and pUL6 
with a scaffold composed of the conserved pUL26 and pUL26.5 proteins (Singer et al., 
2005; Walters et al., 2003). At this stage, individual genome copies enter into 
pre-formed capsids through a nuclear pore complex (Zeev-Ben-Mordehai et al., 2015). 
Afterwards, the mature nucleocapsid moves out of the nucleus and reaches the 
cytoplasm via primary envelopment and de-envelopment at the inner and outer 
nuclear membrane, respectively. At the trans-Golgi network, these capsids are 
packaged into infectious particles. Then, these infectious particles are transported to 
the cell surface by Golgi-derived vesicles. These particles can be released by 
exocytosis or cytolysis or cell-to-cell contact and cell fusion (Owen et al., 2015a).  
 
1.3 Pathogenesis of alphaherpesviruses  
Horizontal transmission of alphaherpesviruses in animals occurs mainly via direct 
contact and to a lesser extent, via aerosol and semen. Vertical transmission is also 
possible. General features of alphaherpesviruses and current knowledge on FeHV1, 
CaHV1 and PrV are described in the following paragraphs, since they are the viruses 
examined in this thesis.  
 
1.3.1 Feline herpesvirus 1 (FeHV1) 
Most cats are exposed to FeHV1 during their lifetime. The virus can survive in the 
environment and on objects for several days. It is easily inactivated by disinfectants, 
antiseptics and detergents. The virus can be transmitted to other cats via ocular, oral 
and nasal secretions. Especially respiratory secretions are causing infections via 
sneezing, contaminated fomites and unhygienic handling practices. 
 
The viral primary infection mainly occurs after 8 weeks of age, since maternal 
antibodies decline at this time (Gould, 2011). Epithelial cells of nasal mucosa, 
conjunctiva and tonsils are the preferential primary replication sites of the virus 
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(Gould, 2011). After several days post infection, ocular and respiratory problems may 
be observed. Conjunctivitis and keratitis are characterized by the formation of 
punctate and dendritic epithelial ulcers. It has been shown that the epithelial ulcers 
might persist for up to 24 days upon experimental inoculation (Nasisse et al., 1989).  
 
Upon primary infection, FeHV1 establishes a lifelong latency in sensory neurons of 
the trigeminal nerve. The viral genome persists in the cell nuclei of the trigeminal 
ganglia, and latency associated transcripts (LATs) are produced in this phase (Ohmura 
et al., 1993).  
 
Latent FeHV1 can be reactivated by a compromised immune system of the host, 
leading to recrudescent clinical disease. This can occur spontaneously or in 
association with various stressors including systematic treatment with corticosteroids, 
co-infections with other agents, and by mental stress due to environment changes 
(Gaskell and Povey, 1977). Although the molecular mechanism of viral reactivation is 
unknown, it is clear that the virus migrates from the neuronal cell body, through 
sensory axons to epithelial tissues and results in clinical or subclinical disease. 
 
1.3.2 Canine herpesvirus 1 (CaHV1) 
CaHV1 is associated with reproductive failure and causes a fetal hemorrhagic disease 
in neonatal puppies. Reproductive failure due to CaHV1 is characterized by infertility, 
resorption, abortion, stillbirth, delivery of poorly developed and compromised 
neonates, or neonatal death (Evermann et al., 2011). Pregnant dogs may deliver weak 
or stillborn puppies after a CaHV1 infection at midgestation or later. Although 
puppies might seem normal at parturition, they may die later. Since maternally 
derived immunity protects the puppies during the first weeks of life, virus infectious 
diseases are not observed in subsequent litters (Decaro et al., 2008).  
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At less than two weeks of age, susceptible puppies infected with CaHV1 might result 
in a fatal generalized necrotizing and hemorrhagic disease. In contrast, older puppies 
and adult dogs infected with CaHV1 often do not show any clinical sign (Carmichael 
et al., 1965). In older dogs infected with CaHV1, the infection seems to be limited to 
the upper respiratory organs. Only a mild rhinitis, pharyngitis and tracheobronchitis 
may be observed (Appel et al., 1969; Okuda et al., 1993). 
 
CaHV1 can be transmitted by direct or indirect contact between animals, primarily 
through contaminated nasal secretions and aerosols. Similar with FeHV1 infections in 
cats, reactivation of latent virus may be provoked by environmental or social stress or, 
experimentally, by immunosuppressive drugs (corticosteroids) or antilymphocyte 
serum (Burr et al., 1996). Latent virus persists in the trigeminal ganglia and other sites, 
such as lumbosacral ganglia, tonsils, and parotid salivary glands. Latently infected 
dogs represent a source of infection for susceptible animals, and this is of particular 
concern in breeding dogs that can ensure CaHV1 transmission through genital 
secretions (Decaro et al., 2008). 
 
1.3.3 Pseudorabies virus (PrV) 
The natural host of PrV is the pig, but the virus may also infect cattle, sheep, horses, 
cats and dogs. In many species, the virus causes a fatal encephalitis except its natural 
host, pigs. PrV has been eradicated from domestic pigs in many countries, but it 
remains enzootic in free-ranging animals which may form a dangerous virus reservoir 
(Wozniakowski and Samorek-Salamonowicz, 2015).  
 
The respiratory tract, especially the upper respiratory tract, is the main entry site for 
the virus. After infection in the respiratory tract, the virus may develop a systemic 
infection through the lymphatic system and blood circulation. In viremic pigs, a low 
number of cell-associated and cell-free virus can be detected (Nawynck and Pensaert, 
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1995; Wittmann et al., 1980).  In pregnant sows, mononuclear blood cells infected 
by PrV may spread the infection, leading to reproductive disorders (Nauwynck and 
Pensaert, 1992). In the first trimester of pregnancy, sows infected with PrV will 
usually reabsorb the fetuses in utero. In the second and third trimester of pregnancy, 
the typical result of the infection is abortion, stillbirths, or weak piglets that die within 
2 days after birth (Pomeranz et al., 2005). 
 
Infections in neonatal piglets cause neurological signs such as vomiting, scratching, 
trembling, ataxia, paralysis and convulsions. The infected piglets may die from severe 
encephalomyelitis. When a PrV infection occurs during the first two weeks of age, 
neonatal piglets are most susceptible with a mortality that reaches 100%. The 
mortality rate decreases to 50% during the third and fourth week of age (Nauwynck, 
1997). PrV establishes latency mainly in neurons of the trigeminal ganglion (Rziha et 
al., 1986).  
 
PrV reactivation in animals normally requires a modulation of the immune system, e.g. 
by a stressful experience (Meier et al., 2015). Identified stressors increasing PrV 
activity include treatment with immunosuppressive agents, concomitant disease 
conditions, transport, poor animal husbandry and farrowing (Pomeranz et al., 2005).  
 
1.4 Characteristics of ocular, respiratory and genital mucosae  
Pathogens face a range of barriers that hamper their invasion during primary contact 
with susceptible hosts. At mucosae, mucus, epithelium, basement membrane and 
lamina propria are firm barriers that alphaherpesviruses need to cross prior to cause a 
generalized infection. The general structure and components of these barriers will be 
described briefly below.  
 
1.4.1 Ocular mucosa 
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The research in this thesis was mainly conducted on feline ocular mucosa. The ocular 
mucosa consists of corneal and conjunctival mucosae. The two mucosae are close to 
each other. The cornea mucosa is the clear front surface of the eye. It is avascular and 
gets its nutrition from tears on the outside, aqueous fluid on the inside, and from blood 
vessels located at the periphery. The conjunctival mucosa extends from the 
limbo-corneal junction of the globe to the mucocutanous junction of the eyelid, 
covering the exposed surface of the ocular globe and lining the inner surface of the 
eyelids. It is richly vascularized, variably pigmented, which is different from the 
corneal mucosa.  
 
1.4.1.1 Corneal mucosa 
The cornea has the same function and structure in cat eyes as in human eyes. The 
corneal mucosa is located at the anterior surface of the eyeball. For cats, there is no 
significant differences between central and peripheral corneal thickness (Gilger et al., 
1993).The cornea mucosa is composed of five layers: epithelial layer, Bowman’s 
layer, stroma, Descemet’s membrane and endothelial layer (Casaroli-Marano et al., 
2015) (Figure 4). The basement membrane is located between the epithelial layer and 
Bowman’s layer. The Bowman’s layer (anterior limiting lamina), stroma (substantia 
propria), Descemet’s membrane (posterior limiting lamina) are corresponding to the 
lamina propria of other mucosal tissues.  
 
Mucus - The normal airway mucus provides important immune functions by 
detoxifying noxious molecules and by trapping and removing pathogens and 
particulates from the airway via mucociliary clearance (Voynow and Rubin, 2009). 
The mucus layer is composed predominantly of mucin glycoproteins. The mucin 
glycoproteins help the spread of the aqueous layer across the eye to ensure that the 
eye remains wet. In the apical surface cells of corneal epithelium, MUC1 and MUC16 
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proteins are found. MUC4 is only located in the central part of the cornea (Gipson, 
2004). 
 
Corneal Epithelium - The outermost layer of the cornea is its epithelium. The 
epithelium is 5-7 cell layers thick, and is composed of a single layer of basal cells and 
cell layers of non-keratinized, stratified squamous epithelial cells (wing cells and 
superficial cells) (Zieske et al., 1994). The basal cells of the central cornea are more 
mature-looking than the basal cells of all other stratified squamous epithelia 
(Srinivasan and Eakins, 1979). The basal cells from the limbo-corneal epithelium are 
proposed to be the stem cells of the corneal epithelium (Lavker and Sun, 2000; Sun 
and Lavker, 2004). The wing cell layer lies between the basal cell layer and the 
superficial cell layer. These cells are progressively displaced anteriorly. They 
eventually become superficial cells, which are eventually desquamated from the 
corneal surface (Masters and Thaer, 1994). The superficial cells are terminally 
differentiated, flattened cells. Superficial cells are held together by tight junctions, to 
form an effective barrier against fluid loss and pathogen penetration. The corneal 









Figure 4. Histologic full-thickness section of a normal human cornea. The cornea consists 
of 5 layers: the epithelium, Bowman’s layer, stroma, Descemet’s membrane and endothelium. 
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The epithelial basement membrane is lying underneath the basal cell layer. The Bowman's 
layer is a smooth, acellular membrane, located between the superficial epithelium and the 
stroma in the cornea of the eye. The stroma consists of collagen fibril lamellae. Descemet’s 
membrane is a thin layer of tissue. The endothelium is a single layer of cells on the inner 
surface of the cornea. Image adapted from images.misssionforvisionusa.org 
Basement membrane - The corneal basement membrane is positioned between the 
basal epithelial cells and the Bowman’s layer. The corneal basement membrane is 
different from that in other tissues (Torricelli et al., 2013). This highly specialized 
extracellular matrix anchors epithelial cells to the stroma and provides scaffolding 
during migration, differentiation, and maintenance of the differentiated epithelial 
phenotype (Torricelli et al., 2013). It undergoes a considerable change during 
embryonic development and appears to have a regional heterogeneity from the center 
to outer limbus (Torricelli et al., 2013). The corneal basement membrane is associated 
with many inherited and acquired corneal diseases (Torricelli et al., 2013). In general, 
the primary components of the basement are collagens, laminins, heparin sulfate 
proteoglycans and nidogens. The functions of these components will be discussed in 
1.4.2. 
 
Lamina propria - Bowman’s layer (anterior limiting lamina), stroma (substantia 
propria), Descemet’s membrane (posterior limiting lamina) are corresponding to the 
lamina propria of other mucosal tissues (conjunctival mucosa, tracheal mucosal et al.).  
 
The Bowman’s layer is located between the epithelial basement membrane and the 
anterior corneal stroma (Lagali et al., 2009). The Bowman’s layer does not correspond 
to the basement membrane, and it is the anteriormost part of the corneal stroma 
(Pavelka and Roth, 2010). It is a smooth, acellular, non-regenerating layer. Major 
components of the Bowman’s layer are collagen fibrils and proteoglycans (Yadav et 
al., 2012). According to Hayashi and co-workers (Hayashi et al., 2002), the cat cornea 
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has a Bowman’s layer which is thinner than the Bowman’s layer in the human eye. 
The Bowman's layer have no critical function in corneal physiology, and may be a 
visible indicator of stromal-epithelial interactions (Wilson and Hong, 2000). In a 
previous study, the layer was postulated as a barrier that prevents traumatic contact 
with the cornea stroma. It is highly associated with stromal wound healing and the 
restoration of anterior corneal transparency at the morphological level (Lagali et al., 
2009). In addition, the Bowman’s layer can serve as a barrier to protect the nerve 
plexus (Lagali et al., 2009).  
 
The corneal stroma is avascular and has a relatively low keratocyte density. It is the 
thickest layer of the cornea. It contains collagen fibers and keratocytes. The stromal 
fibrils are further organized into bundles, or lamellae, and the lamellae course lines 
the full width of the cornea without a break (Bron, 2001). The keratocytes occupy 10% 
of the stroma. Descemet’s membrane is a thin layer of tissue that forms the deepest 
layer of the stroma. It separates the stroma from its innermost cellular layer, the 
endothelium, which consists a single layer of low cuboidal cells. The major 
components of Descemet’s membrane are collagen type IV fibrils and collagen type I 
fibrils (Dua et al., 2013). 
 
1.4.1.2 Conjunctival mucosa 
The feline conjunctiva is structurally similar to the human. It is divided into three 
parts: the palpebral (tarsal) conjunctiva, the bulbar (ocular) conjunctiva and the fornix 
conjunctiva (Figure 5a). The palpebral conjunctiva starts at the mucocutaneous 
junction at the eyelid margin and is firmly adherent to the tarsal plates. The fornix 
conjunctiva is loose and folded, and it is the junction between the bulbar and palpebral 
conjunctivas. The bulbar conjunctiva lines the anterior sclera. 
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Mucus - The conjunctival mucosa produces mucus to keep the eye surface moist and 
protected. The mucin glycoproteins are the major molecular constituents of normal 
mucus. They are large, heavily glycosylated proteins with a defining feature of 
tandemly repeating sequences of amino acids (Voynow and Rubin, 2009). In 
conjunctival epithelium, MUC1, MUC4 and MUC16 are widely distributed. In 
addition, MUC5AC, a gel-forming mucin, is expressed by goblet cells of the 











Figure 5. Vertical section of the human conjunctiva (a) and histologic section of a human 
conjunctiva (b).The different regions of the conjunctiva are shown on the left (a). The 
conjunctival submucosa has two layers: lymphoid and fibrous (b). The conjunctival 
epithelium has 2-3 cell layers. The lymphoid layer consists of a fine network of connective 
tissue with lymphocytes. The fibrous layer contains conjunctival blood vessels and nerves. 
Image adapted from http://www.images.missionforvisionusa.org/anatomy/2005/11/ 
conjunctiva-answers.html website and https://entokey.com/ pathology-of-conjunctiva/ website 
with courtesy of Dr. Tatyana Milman 
 
Epithelium - The conjunctival epithelium is thinner than the corneal epithelium. The 
cell conjunction is less tight in the conjunctival epithelium than in the corneal 
epithelium. It is composed of a non-keratinized, stratified squamous epithelium with 
Fornix conjunctiva 
Bulbar conjunctiva 
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goblet cells, as well as a stratified columnar epithelium. The morphology of the 
conjunctival epithelium varies from region to region. The fornix and bulbar 
epitheliums consist of 3 layers: the superficial layer with cylindrical cells, the middle 
layer with polyhedral cells and the deepest layer with cuboidal cells. The fornix 
conjunctival epithelium holds the highest density of goblet cells (Wei et al., 1993). 
The palpebral conjunctival epithelium does not have the middle layer. 
 
In the conjunctiva, both epithelial cells and goblets cells synthesize mucins to provide 
a barrier against the external environment (Dartt and Masli, 2014). Stratified 
squamous cells synthesize mucins that are trafficked to the surface. Goblet cells can 
also synthesize and secrete a high molecular weight mucin MUC5AC (Gipson, 2004). 
MUC5AC is very protective for the ocular surface against chronic inflammatory 
diseases. 
 
Basement membrane - Most basement membrane components have the same 
distribution pattern in the conjunctival mucosa and the corneal mucosa. Only alpha 
subchains of type IV collagen show a different distribution pattern in the two tissues 
(Fukuda et al., 1999).  
 
Lamina propria The conjunctival submucosa or substantia propria consists of two 
layers (Figure 5b): lymphoid and fibrous. Numerous lymphocytes, mast cells, plasma 
cells, and neutrophils are present within this connective tissue layer. The deepest 
fibrous layer contains the nerves and vessels providing innervation and blood supply 
to the conjunctiva (Giuliano et al., 2002; Singh, 2003). Contrary to the cornea where 
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1.4.2 Respiratory mucosa 
We will focus in this section on the tracheal mucosa, because is the main entry site for 
alphaherpesviruses. The mucus, epithelium, basement membrane and lamina propria 
of the trachea will be described below.  
 
1.4.2.1 Tracheal mucus 
The mucus layer of trachea epithelium is mainly produced by goblet cells, submucosal 
mucous and serous glands. These glands are complex structures that normally produce 
mucus in response to a wide range of different stimulation (Ianowski et al., 2007). The 
thickness of the layer is different between species, location and host health status. In 
the upper respiratory tract, the major mucins are MUC5AC and MUC5B, although 
more types were described (Corfield, 2015). 
 
1.4.2.2 Tracheal epithelium 
The ciliated pseudostratified epithelium of the nose/trachea is composed of 
morphologically distinct epithelial cell types, including basal cells, ciliated cells, 
goblet cells and brush cells. In the ciliated pseudostratified columnar epithelium, basal 
cells are the stem or progenitor cells for the epithelium and differentiate to form the 
other cells during repair after an injury. Ciliated cells are the main cell type in the 
respiratory epithelium. These cells provide the mechanism for moving the mucus 
blanket. Goblet cells are a type of columnar epithelial cells that secrete mucus (Yaghi 
and Dolovich, 2016). Brush cells are characterized by the presence of a tuft of blunt, 
squat microvilli on the cell surface, and express components of the taste-signaling 
cascade and, consequently, are considered to act as chemosensory cells (Kaske et al., 
2007). Furthermore, some other cell types, like immune cells and inflammatory cells 
migrate to and remain within the respiratory mucosa. Immune cells include mast cells, 
intraepithelial lymphocytes, dendritic cells and macrophages (Knight and Holgate, 
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2003). Inflammatory cells refer to neutrophils, macrophages, monocytes, eosinophils 
or basophils that take part in the inflammatory response to a foreign substance.  
 
1.4.2.3 Tracheal basement membrane 
Basement membranes are conserved forms of extracellular matrix (ECM), which are 
located at the basal side of the epithelium. The thickness of a standard basement 
membrane is less than 100 nm (Halfter et al., 2015). The basement membrane forms 
an organized scaffold to provide structural support to the tissue, and also offer 
functional input to modulate cellular function (LeBleu et al., 2007). The basement 
membrane determines the polarity of the epithelium and is a barrier for the epithelial 
cell migration. Proliferating cells are close to the basement membrane and their 
daughter cells are migrating at the upper side (Watt, 1984). Cells interact with the 
basement membrane by binding basement membrane components through basal cell 
surface integrin receptors (Lee and Streuli, 2014). The basement membrane consists 
of a core set of proteins, including laminin, type IV collagen, the glycoprotein 
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Figure 6. General structure of the basement membrane. Epithelial cells secrete at their 
basal side ECM components to synthesize the basement membrane that functions as a 
support/platform and anchorage for the cells. The basement membrane consists of laminin, 
collagen IV, nidogens and the heparin sulphate proteoglycans (HSPG) perlecan and agrin. 
Figure adapted from (Singh et al., 2012). 
 
Laminin is a heavily glycosylated protein with a 12-27% carbohydrate content often 
present as complex-type carbohydrates (Terres et al., 2003). The laminin molecule is 
composed of one α, one β, and one γ polypeptide chain. Up till now, five α, four β, 
and three γ variants were reported. The molecular weight of the laminin is variable 
from 400 to 900 kDa (Yao, 2016). Laminins are contributors to basement membrane 
assembly. The basement membrane diversity arises from the variety in laminin 
isoforms, resulting in highly tissue-specific basement membrane architecture and 
function (Horejs, 2016).  
 
Collagens are the most abundant proteins in mammals. They are the main component 
of connective tissue and are associated with maintaining tissue architecture, cell 
adhesion, angiogenesis and development (Myllyharju and Kivirikko, 2004). The 
major collagen in the basement membrane, collagen type IV, consists of 6 different 
kinds of α-chains (α1–α6), which form three heterotrimers (α1α1α2, α3α4α5, α5α5α6) 
(Horejs, 2016). Among those heterotrimers, α1α1α2 is observed in the basement 
membrane of almost all tissues, while the other two have somewhat limited tissue 
distributions (Khoshnoodi et al., 2008).  
 
Nidogen interconnects the laminin and collagen networks with the help of perlecan 
and thus forms a rigid basement membrane (Figure 6). Nidogens are the smallest 
glycoproteins in the basement membrane, with a size around 150 kDa (Halfter et al., 
2015). Two types of nidogens (nidogen-1 and 2) have been identified. Both nidogens 
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can bind with collagens I and IV. Nidogen-2 binds to laminin and promotes 
high-affinity binding of nidogen-1 (Kohfeldt et al., 1998; Timpl et al., 1983). 
 
Perlecan, agrin and collagen XVIII are heparan sulfate proteoglycans in the basement 
membrane (Halfter et al., 2015). Perlecan is well studied while the other 
proteoglycans are not. Collagen XVIII is a component of basement membranes with 
the structural properties of both a collagen and a proteoglycan (Marneros and Olsen, 
2005). With the cooperation of nidogen, perlecan is responsible for a non-covalent 
linkage of the collagen and laminin networks (Breitkreutz et al., 2013). Agrin 
functions as a bridge between laminin α chains and integrins that interact with the 
coiled-coil region in the β-chain (Singh et al., 2012). 
 
1.4.2.4 Lamina propria  
The lamina propria is located underneath the basement membrane. Functionally, the 
lamina propria regions from the upper respiratory tract and female reproductive tract 
are the mucosal immunity effector sites, while local and regional draining lymph 
nodes and mucosa associated lymphoid tissue are the inductive sites (McGhee and 
Fujihashi, 2012). The lamina propria contains collagenous elastic fibers, fibroblasts, 
lots of lymphocytes, macrophages, occasional mast cells, and eosinophils. The 
immune cells in the lamina propria play a major role in the local immunity (Uematsu 
et al., 2008). Myofibroblasts, a cell type between fibroblasts and smooth muscle cells, 
play a key role in inflammation and wound healing responses. In some conditions, 
myofibroblasts are able to release cytokines and chemokines (Wiseman et al., 2003). 
 
1.4.3 Genital mucosa 
The research in this thesis was mainly conducted on genital epithelium of the canine 
vagina. Layers can be found within vaginal mucosa: mucus, epithelium, basement 
membrane and lamina propria.  
28                                                                      Chapter 1 Introduction 
 
 
1.4.3.1 Genital mucins 
Similar with the ocular and respiratory tract, the genital tract is also covered by a thick 
mucus layer. Mucin types are differentially expressed during the different stages of 
the oestrous cycle, which is also related to fluctuations in sex steroid hormones 
(Cortes et al., 2012). In humans, the vaginal epithelium expresses mucins 1 and 4, and 
vaginal expression of MUC4 seems patchy (Gipson et al., 1997) 
 
1.4.3.2 Vaginal epithelium 
The lower female reproductive tract, consisting of the vagina and ectocervix, is lined 
with a non-keratinized stratified squamous epithelium attached to a basement 
membrane. The different cell types in the epithelium layers are basal cells, parabasal 
cells, intermediate cells and superficial cells (Figure 7). Basal cells are round cells 
with small nuclei, and are considered as the stem or progenitor cell population (Purkis 
et al., 1990). Parabasal cells, another type of progenitor cells, are also round with 
small nuclei. They are the most immature cells in the vaginal epithelium (Brizzolara 
et al., 1999). In addition, they are important markers of intense inflammation. This 
cell population increases during vaginitis (Utian, 1975). Intermediate cells can be 
differentiated in large (with glycogen) and small (without glycogen) cells (Post, 1985). 
During pregnancy and under the strong influence of progestins or androgens, these 
cells show a canoe or boat form and are called navicular cells (Dos Santos et al., 
2017). Superficial cells show the greatest degree of maturation. They are polygonal in 
shape and distinctly flat, sometimes having the appearance of being rolled up 
(Anderson et al., 2014). 
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Figure 7. Histologic section of of the human vaginal epithelium. Vaginal epithelial cells 
are classified as superficial, intermediate, parabasal and basal cells. Image adapted from 
http://www.histology-world.com/photoalbum/displayimage.php 
 
1.4.3.3 Genital basement membrane 
Epithelia are separated from the underlying lamina propria by the basement 
membrane. The components of the vaginal basement membrane does not differ 
significantly from the non-reproductive skin and mucosa except the amnion placentae 
(Chi et al., 2010). A description of these components is discussed in 1.4.2.3. 
 
1.4.3.4 Genital lamina propria 
The vaginal mucosal lamina propria contains many elastic fibers as well as a dense 
network of blood vessels, lymphatic and nerve supply, but does not contain glands or 
mucosal muscular layer (Lorenzen et al., 2015). It is responsible for the support and 
nutrition of the vaginal lining and is fundamental for the architecture of the vaginal 
wall. The defensive cells in the lamina propria contain neutrophils, macrophages, 
lymphocytes, plasma cells, and mast cells. Neutrophils and macrophages may migrate 
from the lamina propria to the vaginal epithelium (Hussin et al., 2014).  
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1.5 Plasminogen activator-plasmin system 
Many pathogens break extracellular matrix proteins of interstitial spaces and 
connective tissues by the use of many proteases or surface-bound plasminogen and 
matrix metalloproteinases recruited from the host (Singh et al., 2012). Proteases are 
enzymes that hydrolyse peptide bonds, and are necessary to degrade extracellular 
matrix (DeClerck et al., 2004). They are classified according to their catalytic activity: 
serine-, cysteine-, metallo- and aspartic peptidases. Previous studies demonstrated that 
serine protease activity is involved in PrV invasion through the basement membrane 
(Glorieux et al., 2011). The plasminogen activator-plasmin system is the principal 
serine protease mediating extracellular matrix degradation (Skrzydlewska et al., 2005). 
As a valuable candidate, some components of the system are expressed/found in 
epithelial cells and the extracellular matrix (Mehta and Shapiro, 2008). In this part, 
the detail of plasminogen activator-plasmin system will be discussed.  
 
Plasminogen is the inactive zymogen form of plasmin, an enzyme that plays a crucial 
role in the dissolution of fibrin clots, the extracellular matrix and other key proteins 
involved in immunity and tissue repair (Law et al., 2013). Plasminogen is produced 
primarily by the liver, circulates in plasma at a high concentration (2 µM), and is also 
found at high concentrations in interstitial fluid (Hoover-Plow, 2010). Plasminogen is 
also present in tissues and organs (Raum et al., 1980; Zhang et al., 2002). Under 
physiological conditions, plasminogen is activated by tissue-type plasminogen 
activator (tPA) and urokinase-type plasminogen activator (uPA) via the classical 
cleavage mechanism (Verhamme et al., 2015) (Figure 8). Some other proteases, such 
as kallikrein, factors XIa and XIIa are also capable of functioning as plasminogen 
activators (Backes et al., 2000; Miles et al., 2003). Besides, the process 
of plasminogen activation is also controlled by inhibitors and their receptors 
(Castellino and Ploplis, 2005). 
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Figure 8. Schematic representation of the plasminogen activator-plasmin system digesting 
the extracellular matrix. Plasminogen binds to its receptors and is subsequently converted to 
plasmin by plasminogen activators (uPA, tPA). The proteolytic activities of uPA and plasmin 
are antagonized by plasminogen activator inhibitor-1 and -2 (PAI-1, PAI-2) and by 
α2-antiplasmin, respectively. tPA is mainly antagonized by PAI-1. ECM, extracellular matrix. 
Image adapted from (Didiasova et al., 2014). 
 
1.5.1 Plasminogen and plasmin 
There are two types of plasminogen: Glu-plasminogen and Lys-plasminogen. Glu- 
plasminogen, the circulating form of plasminogen, is a single-chain multidomain 
protien composed of 791 amino acids, which has seven different structural domains: 
an N-terminal pre-activation peptide (amino-terminal glutamic acid (Glu) 
plasminogen N-terminal peptide), 5 kringle domains and the C-terminal trypsin-like 
serine protease domain (Figure 9) (Law et al., 2012). Lys-plasminogen is a modified 
form of Glu-plasminogen, after removal of a 77-residue amino-terminal peptide by 
plasmin (Zhang et al., 2003). Lys-plaminogen can be activated to plasmin more 
readily than Glu-plasminogen. 
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Figure 9. Full length native 3D structure of native human Glu-plasminogen. The activation 
peptide, the 5 kringle domains, and the serine protease domain (where the catalytic site is 
located) are highlighted with different colors. After removal of a 77-residue amino-terminal 
peptide (AA 1-77, indicated in red), Glu-plasminogen is converted into Lys-plasminogen. The 
cleavage of the Arg561-Val562 peptide bond in plasminogen leads to the formation of 
plasmin. Image adapted from Correia et al. (2015). 
 
Kringle domains are autonomous protein domains that fold into large loops stabilized 
by 3 disulfide linkages. The kringle domains mainly help plasminogen binding to 
large substrates (bacterial proteins, fibrinogen and cell surface) and also to some small 
ligands. These kringle domains appear to function independently. When plasminogen 
kringles are formed in combination, it can inhibit cell migration (Castellino and 
Ploplis, 2005). Kringle domains are also found in other proteins of the fibrinolytic 
system, such as tPA, uPA, and in the contact pathway of coagulation protein, FXII 
(Gunzler et al., 1982; Magnusson et al., 1975). 
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The C-terminal trypsin-like serine protease domain, also known as the catalytic 
domain, contains the cleavage site for plasminogen activator. The cleavage of the 
Arg561-Val562 peptide bond in plasminogen leads to the formation of plasmin, which 
contains a heavy chain of 561 amino acid residues, disulfide linked to a light chain of 
230 amino acid residues. The heavy chain consists of the activation peptide and 5 
kringles. The activation peptide is called this way since cleavage of it (normally 
promoted by plasmin) from full-length Glu-plasminogen results in Lys-plasminogen 
that exists in a more relaxed conformation, making it more easy to become activated 
by plasminogen activators (Mauro et al., 2013). The plasmin light chain contains the 
carboxyl terminus of plasminogen, which comprises the catalytic domain that 
resembles that of the serine protease family (Bhattacharya et al., 2012). It is a compact 
molecule that can recruit adapter molecules. The catalytic triad of amino acids that 
define the serine protease activists consists of His603, Asp646, and Ser741 for human 
plasmin (Castellino and Powell, 1981).  
 
Plasminogen can adapt two distinct conformations, termed closed and open, which 
highly influences its activation capability. The closed state (tight conformation) is a 
compact state seen in full-length plasminogen. In this conformation, plasminogen is 
poorly activated (Urano et al., 1987). uPA or tPA cannot easily activate the full-length 
plasminogen in its closed conformation. The lysine binding sites in the heavy chain 
are buried, which results in a functionally inactive molecule (Law et al., 2013). In 
case of binding to fibrin or the cell surface, full-length plasminogen switches into an 
open conformation (Law et al., 2013). This open conformation is more flexible. It is 
readily activated when the activation peptide is displaced from its kringle binding 
sites (Bhattacharya et al., 2012).  
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1.5.2 Plasminogen activators  
Plasminogen activators (PAs) include physiological and non-physiological molecules. 
Two physiological PA have been recognized: tissue-type PA (tPA) and 
urokinase-type PA (uPA), which binds to a cellular uPA receptor (uPAR) (Lijnen et 
al., 1991; McCoy et al., 1991). Both uPA and tPA are weak proteolytic enzymes with 
the function to cleave plasminogen into the active serine protease plasmin, which 
results in a two-chain plasmin molecule that are connected by a single cysteine bridge. 
uPA seems to be the primary plasminogen activator in eukaryotic cell migration 
processes, and is recognized as a vital component for plasmin generation during cell 
migration and invasion, under physiological and pathological conditions (Fortenberry, 
2013; Ghosh and Vaughan, 2012; Kindell et al., 2015). tPA is the main plasminogen 
activator in fibrinolysis, regulates airway disease and maintenance of vascular patency 
(Lijnen and Collen, 1995; Nassar et al., 2010). Besides, invasive pathogens have 
evolved plasminogen activators, such as streptokinase and staphylokinase. Neither 
streptokinase nor staphylokinase is an enzyme, which is different from tPA and uPA 
(Dahiya et al., 2005). Streptokinase and staphylokinase form a bimolecular 1:1 
complex with plasminogen that in turn catalyzes the conversion of free plasminogen 
into plasmin (Dahiya et al., 2005). The activities of PAs are controlled by specific 
plasminogen activator inhibitors thereby restricting the generation of plasmin for extra 
cellular matrix (ECM) as well as intravascular fibrin degradation (Andreasen et al., 
1986; Vassalli et al., 1984). 
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1.5.2.1 Tissue Plasminogen Activator (tPA)  
tPA is a serine protease that is secreted in a single-chain, which contains five 
structural domains (Figure 10): the fibronectin finger, epidermal growth factor domain, 
kringle 1 and 2, and serine protease domain. The fibronectin finger domain, together 
with the kringle 2, provides tPA with a high affinity for fibrin (Banyai et al., 1983; 
Verheijen et al., 1986). A large serine protease catalytic domain is located at the 
carboxyl terminus, similar to uPA. The single chain tPA is cleaved at the Arg275- 
Ile276 bond by plasmin or kallikrein, creating a two-chain molecule held together 
through a single disulfide bond (Wallen et al., 1983). The heavy chain consists of a 
fibronectin finger, an epidermal growth factor domain and two kringle domains. The 
light chain is able to activate plasminogen, but requires the heavy chain for 
fibrin-binding and fibrin-stimulation. Both the single-chain and the two-chain forms 
of tPA are active, but the two-chain form has relatively higher proteolytic activity 
(Rijken et al., 1982). 
 
Figure 10. A theoretical structure of the full tissue plasminogen activator in humans. The 
kringle domains, fibronectin finger, epidermal growth factor (EGF) and serine protease 
domains are marked.  
Image adapted from https://commons.wikimedia.org/wiki/File%3AT-PA.png 
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Normal physiological tPA concentrations do not induce systemic plasmin generation. 
Fibrin is generally thought to regulate plasminogen activation leading to fibrinolysis 
through recruitment and co-localization of both tPA and plasminogen on its surface. 
The stimulation of endothelial cells at the site of damage ensures rapid local release of 
active unbound tPA to be incorporated into the clot (Oliver et al., 2005). tPA binds to 
fibrin and activates fibrin-bound plasminogen more rapidly than it activates 
plasminogen in the circulation (Lijnen, 2001).  Binding sites for tPA have been 
identified on endothelial cells. This involves annexin 2 (A2), a calcium and 
phospholipid binding protein on the plasma membrane that has been shown to 
enhance tPA-dependent plasminogen activation that is C terminal lysine dependent 
(Hajjar et al., 1987). A2 has also been identified on the surface of at least one 
herpesvirus, CMV (Raynor et al., 1999).  
 
1.5.2.2 Urokinase Plasminogen Activator (uPA) 
The serine protease uPA (50 kDa) is the product of the PLAU gene, synthesized by 
vascular endothelial and smooth muscle cells, by epithelial cells, fibroblasts, 
monocytes/macrophages, and also by cells of malignant tumors of different origin 
(Stepanova and Tkachuk, 2002). This protein is secreted as a single chain form. The 
lack of viable crystals for structure determination of intact uPA is probably due to the 
high degree of structural and motile independence of the domains. An overview of the 
uPA molecule is shown schematically in Figure 11. The single chain form is a 
prozymogen, which upon plasmin-mediated proteolytic cleavage is converted to an 
active two-chain form (Skriver et al., 1988). This uPA consists of an A-chain (157 
residues) and a glycosylated B-chain (253 residues), which are linked by the disulfide 
bridge at cys148 and cys279. Further cleavages at lys135 and arg156 produce 
low-molecular-weight (31 kDa) uPA. Both high- and low-molecular-weight species 
are enzymatically active (Schaller and Gerber, 2011). The epidermal growth factor 
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domain (EGF) contains a binding site for the uPA receptor (uPAR). The kringle 
domain lacks lysine binding sites, which plays an important role in the binding to the 
cell surface and fibrin (Schaller and Gerber, 2011). uPA has a characteristic, basic 
sequence motif that has an affinity for heparin, which may be involved in the binding 
of uPA to components of the extracellular matrix such as laminin-nidogen (Siren et al., 
1992; Vaheri et al., 1992). 
 
Figure 11. The schematic representation of the A-chain and B-chain of urokinase-type 
plasminogen activator (uPA).  uPA consists of an A-chain (157 residues) and a glycosylated 
B-chain (253 residues). The epidermal growth factor domain (EGF, AA 5-46), the kringle 
domain (kringle, AA 50-131) and the catalytic domain (catalytic, AA 148-411) are highlighted 
with different colors. Image adapted from the RCSB PDB (www.rcsb.org) of PDB ID 2I9A 
and 4XSK. 
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uPA provides a system for pericellular plasminogen activation. uPA binds with high 
affinity to uPAR on the cell surface. Those two components are key members in 
processes that require concentrated proteolytic activities, including pathological 
processes (such as tumor invasion), as well as physiological processes, such as wound 
healing. On the surface of extravascular cells, uPA/uPAR complexes mediate 
plasminogen conversion into plasmin. The plasmin generated at the cell surface is 
involved in proteolytic degradation of the extracellular matrix. This remodeling 
process contributes to the upregulation of cell migration and proliferation (Dano et al., 
1985).  Jimenez et al. (1997) have demonstrated that uPA can accelerate the wound 
healing process in a murine model. In addition, the migration of corneal epithelial 
cells has been shown to require degradation of the basement membrane by the release 
of cellular uPA (Legrand et al., 2001). 
 
1.5.3 Plasminogen activator inhibitors   
The plasminogen activator inhibitor-1 (PAI-1), PAI-2 or PAI-3 regulate uPA and tPA. 
All of them are glycoproteins that belong to the family of serine proteases (Kruithof, 
1988). During the physiological condition, these inhibitors have a variety of 
conformations. They are stable when they snap into their target protease. PAI-3 can 
inhibit both uPA and tPA albeit with a much slower rate than PAI-1 and -2 (Rijken, 
1995). Besides, PAI-1 is the most universal and most rapidly acting physiological 
inhibitor of both uPA and tPA. On the other hand, PAI-2 can inhibit both two-chain 
uPA and two-chain tPA, but is less eff ective towards single-chain tPA and does not 
inhibit single-chain uPA (Bhattacharya et al., 2012). 
 
1.5.3.1 Plasminogen activator inhibitor-1 
PAI-1, also known as endothelial plasminogen activator inhibitor or serpin E1, is a 54 
kDa protein that exists in (i) a native inhibitory form, (ii) an inactive latent form, (iii) 
complexed with proteinases and (iv) a cleaved form (Hekman and Loskutoff, 1985). 
Chapter 1 Introduction                                                                       39 
PAI-1 assembles complexes both with single-chain and two chain tPA and with 
two-chain uPA, but is more selective for tPA (De Taeye et al., 2004). In plasma, there 
is a large molar excess of active PAI-1 over tPA. Most of tPA is in complex with 
PAI-1 to regulate constitutive plasminogen activation (Schaller and Gerber, 2011). 
Platelets have much PAI-1 in its inactive form (Booth et al., 1988). Platelets that are 
involved in the formation of a fibrin clot are activating PAI-I by their α-granules 
(Juhanvague et al., 1984). There is enough active PAI-I to inhibit the plasminogen 
activator tPA and uPA and protect clot formation (Brogren et al., 2004). In contrast, 
activated platelets are thought to provide a surface for enhanced plasminogen 
activation by promoting an interaction between tPA and plasminogen and for 
protection of plasmin from α2-antiplasmin (Loscalzo et al., 1995).  
 
1.5.3.2 Plasminogen activator inhibitor-2   
The PAI-2 can be found in two forms: a nonglycosylated intracellular form (42kDa) 
and a glycosylated, secreted extracellular form (60kDa) (Genton et al., 1987). PAI-2 
rapidly inhibits uPA, but tPA very slowly (Kawano et al., 1970; Kruithof et al., 1995). 
PAI-2 secreted by monocytes is involved in uPA-mediated cell migration, whereas 
intracellular PAI-2 prevents apoptosis (Dickinson et al., 1995; Kirchheimer and 
Remold, 1989; Kumar and Baglioni, 1991). 
 
1.5.3.3 Plasminogen activator inhibitor-3   
PAI-3, also known as Protein C inhibitor, is synthesized in the liver and in numerous 
steroid-responsive organs. It is a serine proteinase inhibitor that can inhibit enzymes 
in blood coagulation, fibrinolysis and fertility. The role of PAI-3 in regulating the 
blood coagulation mechanism is still unknown, as it can inhibit both procoagulant and 
anticoagulant enzymes (Meijers et al., 2002). 
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1.5.4 α2-antiplasmin 
α2-antiplasmin is the chief physiological inhibitor of plasmin. This glycoprotein 
forms a complex with plasmin by binding to kringle 1-3 of plasmin (Wiman and 
Collen, 1979). Since the same lysine-binding kringle sites mediate plasminogen 




Another broad-spectrum proteinase inhibitor, α2-macroglobulin, can also inhibit 
plasmin. α2-macroglobulin forms a noncovalent complex with plasmin, and this 
process happens when the α2-antiplasmin concentration is low (Aoki et al., 1978). 
 
1.5.4 Virus and plasmino(gen) interaction  
The roles of the plasminogen activator-plasmin system in normal and pathologic 
processes have expanded significantly with the introduction of new gene-targeting 
techniques, and the roles of the plasminogen activator-plasmin in viral infections have 
become more clear.  
 
Plasminogen is involved in the infection and replication of various enveloped viruses. 
During H1 or H3 influenza virus infection, plasmin can make a HA0 cleavage in cell 
cultures (Hamilton and Whittaker, 2013). Annexin A2 is a cellular protein which 
promotes the formation of lipid micro-domains that are necessary for the budding of 
virus from infected host cells. When incorporated in influenza virus by converting 
plasminogen into plasmin, annexin A2 was shown to enhance viral replication 
(LeBouder et al., 2008). Plasminogen was shown to promote influenza virus 
replication through annexin A2 in the absence of neuraminidase (LeBouder et al., 
2010).  
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HSV1 enhance the generation of plasmin and plasmin enhances cell infection by HSV. 
It was shown that plasmin generation from its purified precursor plasminogen by 
tissue plasminogen activator increased in the presence of purified HSV1, and this 
process relied on the protease activated receptors (Pryzdial et al., 2014). This 
simultaneous generation of clot-dissolving and -forming proteases may explain why 
some enveloped viruses such as HSV1 rarely cause thrombosis (Pryzdial et al., 2014). 
Severe cute respiratory syndrome coronavirus (SARS-CoV) is a virus may cause 
acute respiratory disease and acute lung injury. Following SARS-CoV infection, uPA 
activity increased in a dose-dependent manner, and dysregulation of the urokinase 
pathway caused more severe lung pathology (Gralinski et al., 2013). In addition, the 
urokinase pathway and ECM remodeling are important for regulating SARS-CoV 
pathogenic outcomes (Gralinski et al., 2013). Serpine1 is a negative regulator of 
urokinase pathway, and it inhibits uPA activity. In SARS patients, Serpine1 is highly 
expressed (de Lang et al., 2007). In a Serpine1 knockout mouse model, the virus 
infection resulted in lethal disease with extreme lung pathology (Gralinski et al., 
2013). By contrast, in a tPA-deficient mice model, the virus infection increased 
exudates in the lung (Gralinski and Baric, 2015). These results indicate that the 
dysregulation of these components are closely associated with SARS-CoV infection. 
1.6 Concluding remarks 
Viruses must be able to overcome cellular and non-cellular physical barriers in order 
to successfully establish an infection. During the mucosa infection, they have 
developed mechanisms to establish primary infection and cross the basement 
membrane barrier. ECM degradation and remodelling have been demonstrated to play 
a key role in governing organ branching by providing structural integrity and 
regulating diverse cellular processes. However, there are still some challenging issues 
that remain to be resolved. One aspect of BM passage that we have not discussed here 
is the role of the local cellular immunity in breaking down ECM during a microbial 
invasion. Immune cells can produce large quantities of proteases upon stimulation at 
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the site of inflammation, and this may break important defense barriers such as the 
BM, allowing pathogens to invade deeper tissues. But on the other hand, 
inflammation also increases the risk that pathogens will be recognized and neutralized 
by the immune system. 
 
As the BM represents one of the first barriers encountered by the pathogen, dissecting 
pathogen interactions with, and mechanisms to cross the BM may provide interesting 
leads towards developing novel antimicrobial drugs. However, it is important to bear 
in mind that the in vitro knowledge on this topic does not automatically lead to an 
effective in vivo implementation. Improved in vitro models that can more accurately 
reflect the in vivo environment will provide excellent tools for the identification and 
characterization of putative adhesion and invasion mechanisms before progressing to 
the use of animal models.   
 
The invasive capacity of various microorganisms is directly linked to the 
characteristics of the species in addition to host proteases that degrade structural ECM 
proteins. Generally, underlying mechanisms for binding to and breakdown of the BM 
are better studied for bacteria and fungi than for viruses. Bacteria and fungi degrade 
ECM by many ways, including binding to host plasminogen. In recent years, protease 
inhibitors have been considered as an effective antimicrobial therapeutic approach to 
control the invasive capacity of pathogens and also to hinder host ECM degradation 
(Doyle et al., 2007; Hiemstra, 2002). It will be interesting to identify the possible viral 
factors that are required for efficient penetration through the BM and ECM. If the 
protease activity plays a role, as recently demonstrated by a herpesvirus (Pryzdial et 
al., 2014), then the use of protease-inhibitors might be a useful anti-viral strategy. Still, 
to further develop the potential use of protease-inhibitors as antimicrobial targets, 
there is a need for identification of all concerned signals, factors and domains during 
microbial invasion.  
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In conclusion, viruses have evolved different strategies to cross the basement 
membrane. For herpesvirus basement membrane penetration, it may be associated 
with plasminogen activator-plasminogen system activation. Plasminogen is associated 
with virus infection and replication by many ways. Fundamental insights in these 
invasion mechanisms of herpesviruses could be a promising road towards new 
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The mucosal surfaces represent preferential sites of entry for many alphaherpesviruses. 
The basement membrane, a barrier underlying the epithelium which involves serine 
protease activity, hampers free passage of alphaherpesviruses towards deeper cell 
layers. Previous studies have demonstrated that alphaherpesviruses have developed 
different mechanisms to overcome this barrier. Many alphaherpesviruses spread 
across the basement membrane in a plaque-wise manner, in which the virus replicates 
and spreads by direct cell-to-cell contact, resulting in (local) breakdown of the 
basement membrane. The mechanism underlying this breakdown of the basement 
membrane is not well understood. A better understanding will generate new leads 
towards the development of novel antiviral strategies. 
 
The alphaherpesviruses feline herpesvirus 1 (FeHV 1) and canine herpesvirus 1 
(CaHV 1) cause important diseases in cats and dogs. Before this PhD research, it 
remained unknown if FeHV 1 and/or CaHV 1 cross the basement membrane. In the 
present thesis, feline and canine ocular, respiratory and genital mucosa explants were 
established ex vivo and the viral dynamics of FeHV 1 and CaHV 1 were analyzed 
using these mucosal explants (Chapter 3 and Chapter 4). 
 
In addition, by the use of pseudorabies virus (PrV) and porcine respiratory mucosa 
explants, the mechanism of alphaherpesvirus invasion across the basement membrane 
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3.1 Abstract 
Feline herpesvirus 1 (FeHV1) is a major cause of rhinotracheitis and ocular diseases 
in cats. In the present study, the viral replication at the primary infection sites was 
studied using feline respiratory and ocular mucosa explants. The explants of three cats 
were maintained in an air-liquid culture up to 96 hours without loss of viability. After 
inoculation with FeHV1 (C27), no evidence of infection was noted in corneal 
epithelium, while plaque-wise replication was observed in conjunctival and tracheal 
mucosae beginning from 24 h post inoculation (hpi). The viral plaque diameters 
increased over time in trachea and conjunctiva and were larger in tracheal explants 
than in conjunctival explants at 48 hpi. FeHV1 penetrated the basement membrane in 
conjunctival and tracheal explants between 24 and 48 hpi. At 48 and 72 hpi, viral 
invasion was going deeper in tracheal explants than in conjunctival explants. Our 
study indicates that FeHV1 has a better capacity to invade the respiratory mucosa than 
the conjunctival mucosa, and prefers the conjunctiva, but not the cornea as a portal of 
entry during ocular infection. 
 
3.2 Introduction  
Feline herpesvirus 1 (FeHV1), a member of the alphaherpesvirus subfamily, causes 
infections in Felidae worldwide, and is responsible for the upper respiratory tract 
infections known as feline viral rhinotracheitis in domestic cats (Gaskell et al., 2007). 
The characteristics of FeHV1 replication are similar to those of many other 
alphaherpesviruses: a short replication cycle, lifelong latency mainly in neurons, and a 
narrow host range (Maes, 2012). Clinically, primary FeHV1 infections typically cause 
acute upper respiratory tract and ocular diseases in domestic cats, characterized by 
sneezing and nasal discharge, conjunctivitis and cornea ulceration, and usually end 
with latent and chronic infections (Thiry et al., 2009). The virus may be reactivated, 
especially when the host is immunocompromised, and cats that experience frequent 
FeHV1 recurrences can be difficult to treat (Gaskell et al., 2007; Maggs, 2005). 
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FeHV1 primarily replicates in epithelial cells of ocular and respiratory mucosae, 
which include conjunctivae, nasal septum, turbinates, nasopharynx and upper trachea, 
resulting in surface epithelial erosion and inflammation (Binns et al., 2000; Filoni et al. 
2006; Jacobi and Dubielzig, 2008). After release from these cells, the virus enters 
axons of sensory neurons and travels to the trigeminal ganglion where it establishes 
lifelong latency (Maes, 2012). Sometimes, a severe conjunctivitis may be 
accompanied by cornea ulceration, but whether the cornea epithelium is a portal for 
primary FeHV1 infection is unclear. A feline cornea cell line has been found to be 
susceptible for FeHV1, but primary cornea FeHV1 infection is rarely observed in cats 
under natural conditions (Andrew, 2001; Sandmeyer et al., 2005; Townsend et al., 
2013). Upon experimental inoculation into the conjunctival sacs of cats, FeHV1 was 
isolated from both corneal and conjunctival samples. However, histologic lesions 
were nearly exclusively found in conjunctival samples (Townsend et al., 2013). 
Ocular inoculation by intrastromal injection or topical application after scarifying the 
epithelium resulted in viral replication in both cornea and conjunctiva. Viral antigens 
were mainly observed in the conjunctival epithelium and to a lesser extent in the 
corneal epithelium (Nasisse et al., 1989). The host possesses several barriers that 
hamper invasion of pathogens. One essential barrier is the basement membrane (BM) 
underneath the epithelia (Martinez-Hernandez and Amenta, 1983). Previous studies in 
our laboratory have shown that alphaherpesviruses behave differently at the BM. The 
replication of equine herpesvirus 4 (EHV4) is restricted to the respiratory epithelium 
of the upper respiratory tract (Vandekerckhove et al., 2011). Herpes simplex virus 1 
(HSV1), suid herpesvirus 1 (PRV) and bovine herpesvirus 1 (BoHV1) penetrate 
through the BM, to reach and infect susceptible cells located in the underlying 
connective tissues (Glorieux et al., 2011a,b; Steukers et al., 2012b). Equine 
herpesvirus 1 (EHV1) infects epithelial cells, but not underlying fibroblasts. Instead, it 
hijacks monocytes in the epithelium to invade its host (Vandekerckhove et al., 2010). 
Little is known about how FeHV1 behaves at respiratory and ocular mucosae. Since 
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FeHV1 ocular and respiratory infections in domestic cats resemble HSV1 infections 
in humans in many aspects, a better characterization of the pathogenesis of FeHV1 
infections may contribute to better insights in human alphaherpesvirus infections. 
Feline tracheal mucosa explants have already been used to study the mode of spread 
of FeHV1 in the respiratory epithelium (Leeming et al., 2006). The present study is, 
however, the first to set up mucosa explant models of feline ocular tissues. Kinetics of 
FeHV1 dissemination, including the interaction with the BM and the connective tissue 
underneath, were studied in both ocular and respiratory explants. The ex vivo explants 
have proven to be valuable for the investigation of the mucosal invasion of various 
alphaherpesviruses from horses, pigs, cattle and humans (Vandekerckhove et al., 2011; 
Steukers et al., 2012b; Glorieux et al., 2011a,b). 
 
3.3 Materials and methods  
3.3.1 Animals  
This study was approved by the Ethical Committee of the Faculty of Veterinary 
Medicine, Ghent University (application EC2012/043). Cats were examined in 
veterinary clinics, blood was collected to determine FeHV1 specific antibody titers 
with a complement-dependent seroneutralization (SN)-test. Gender and breed were 
not considered in this experiment. Three seronegative cats without any ocular or 
respiratory symptoms were selected for this experiment. Two cats were 4 years old, 
the third was 9 years old. Cats were sedated by intramuscular injection of a mixture of 
Ketamin (0.05 mL/kg; Anesketin®, Eurovet, Heusden Zolder, Belgium) and 
Midazolam (0.05 mL/kg; Dormicum®, Roche, Brussels, Belgium). Then, cats were 
euthanized by intracardial injection of 20% sodium pentobarbital (1 mL/1.5 kg; Kela 
Laboratories, Hoogstraten, Belgium). Within 10 min, the whole cornea, palpebral 
conjunctiva and proximal trachea were harvested in a laminar flow hood using sterile 
equipment.  
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3.3.2 Air-liquid explant culture  
The protocols for making feline ocular and respiratory explants were similar. In brief, 
tissues were transferred in ice-cold medium containing phosphate-buffered saline 
(PBS), supplemented with 1 µg/mL gentamycin (Invitrogen, Paisley, UK), 1 mg/mL 
streptomycin (Certa, Braine l’Alleud, Belgium), 1 mg/mL kanamycin (Sigma, St. 
Louis, MO, USA), 1000 U/mL penicillin (Continental Pharma, Puurs, Belgium) and 5 
µg/mL amphotericin (Bristol-Myers Squibb, New York, USA). Then, the tissues were 
cut into equal sections with a size of approximately 16 mm2. The tracheal tissues were 
taken with cartilage. Then, the tissues were placed with the epithelium upwards on 
sterile gauzes in individual wells of a 6-well plate. To mimic the air-liquid interface, 
only a thin film of culture medium covered the surface of the explants at 37 °C and 5% 
CO2 up to 96 h. The culture medium consisted of 50% DMEM (Invitrogen)/50% 
Ham’s F-12 Gluta-MAX (Invitrogen), supplemented with 0.1 mg/mL streptomycin 
(Certa), 100 U/mL penicillin (Continental Pharma) and 1 µg/mL gentamycin 
(Invitrogen). For cornea culture, the system was optimized by adding 5% dextran in 
the culture medium to prevent excessive swelling of the cornea (Redbrake e et al., 
1997). At each time point, one explant from each tissue of each animal was randomly 
selected for viability analysis. At 24 h post cultivation, the remaining explants were 
used for viral inoculation.  
 
3.3.3 Tissue viability  
Tracheal tissues were observed under an inverted microscope, and only tissues with 
strong cilia beating were used. An In Situ Cell Death Detection Kit (Roche 
Diagnostics, Switzerland) was used for detection of apoptotic cells, based on terminal 
deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL). A Hoechst 
staining was performed to stain the cell nucleus. The test was performed according to 
the manufacturer’s guidelines. The amount of TUNEL-positive cells was counted in 
five randomly selected fields of 100 cells in both epithelium and lamina 
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propria/stroma at 0, 24, 48, 72 and 96 h post cultivation. A fluorescence microscope 
(Leica TCS SP2 confocal microscopy) was used to analyze all samples.  
 
3.3.4 Virus inoculation  
FeHV1 strain C27 was kindly provided by Dr. R. Maes (College of Veterinary 
Medicine, Michigan State University, USA). The strain C27 had previously received 
an unknown number of passages. The virus was passaged once more in Crandell Rees 
feline kidney (CRFK) cells in our laboratory and this virus was used to inoculate the 
explants. At 24 h after cultivation, the explants were washed twice in culture medium 
in a 24-well plate (Nunc). Then, explants were inoculated with 1 ml medium 
containing 107.0 TCID50/mL FeHV1 for 1 h at 37 °C. After inoculation, explants were 
washed three times and then replaced on the gauze. Explants were collected at 0, 24, 
48 and 72 hpi. All samples were embedded in a cryoprotection medium (Methocel, 
Fluka (Sigma)) and frozen at −70 °C.  
 
3.3.5 Immunostaining  
Immunostaining of sections was performed as previously described (Steukers et al., 
2012b). Sections were fixed in methanol (-20 °C, 100%). To evaluate the distribution 
of FeHV1 infected epithelial cells and FeHV1 penetration underneath the BM, a 
double staining was performed. Mouse anti-collagen VII antibodies (Sigma) (1:100 in 
PBS, 1 h, 37 °C) and goat anti-mouse Texas Red® antibodies (Molecular Probes) 
(1:50 in PBS, 1 h, 37 °C) were applied to visualize the BM. After washing, an 
FITC-labeled anti-FeHV1 polyclonal antiserum (VMRD, Pullman, WA, USA) 
(undiluted, 1 h, 37 °C) was used to visualize virus positive cells in the explants. At 
each examined timepoint, a mock-inoculated tissue was enclosed. Sections were 
mounted and analyzed by confocal microscopy (Leica TCS SP2 confocal microscopy). 
A quantitative reproducible and complete three-dimensional picture of the horizontal 
and vertical spread of FeHV1 in the mucosa was obtained by confocal microscope 
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analysis of serial tissue sections. An extended focus image in the confocal microscope 
was used to display three dimensional information. 
 
3.3.6 Statistical analysis  
Prior to statistical analyses, all variables were checked for assumptions of ANOVA 
(normality and homoscedasticity) by Shapiro–Wilk’s and Levene’s test. Viral plaque 
diameter values were log-transformed to meet assumptions of normality and 
homoscedasticity. A three-way ANOVA, mixed effects model, was used to identify 
significant differences in viral plaque diameter (i) over different time points post 
inoculation, (ii) between respiratory and ocular mucosa explants and (iii) between 
three random seronegative cats. A post-hoc Scheffé’s test was carried out in order to 
compare separate groups. 
 
Since TUNEL-staining data and viral plaque penetration depth data were 
heteroscedastic after log-transformation, a Kruskal–Wallis’ test followed by Mann–
Whitney’s post-hoc test were performed. For all statistical tests used, P-values <0.05 
were considered statistically significant. All analyses were conducted in IBM SPSS 
Statistics for Windows, version 22.0 (IBM Corp, Armonck, NY, USA). 
 
3.4 Results  
3.4.1 Viability  
The effect of cultivation on the viability of explants is shown in Table 1. The 
percentages of apoptotic cells in both epithelium and lamina propria were determined 
by confocal microscopy at each time point. The percentage of apoptotic epithelial 
cells slightly but significantly increased over time post cultivation in cornea, 
conjunctiva and trachea explants (all P < 0.05). Similar results were found for cells 
present in the lamina propria. The highest percentage of apoptosis (8.2 ± 5.3) was 
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observed in tracheal explants among cells in the lamina propria but mean viability 
remained above 90%. 
 
Table 1. Occurrence of apoptosis in epithelium and lamina propria as a parameter for the 
effect of in vitro culture on the viability of feline ocular and respiratory mucosa explants. 
TUNEL-positive cells were counted from five randomly chosen fields of 100 cells. Values are 
given as means ± SD. 
 
Tissue Layer 
% of TUNEL-positive cells at … h post cultivation 
0 24 48 72 96 
Cornea Epithelium 1.3±0.3 1.5±0.5 0.9±0.3 1.3±0.7 2.1±0.8 
 Lamina propria 0.8±0.6 2.9±0.5 2.3±2.5 3.8±2.6 5.2±3.5 
       
Conjunctiva Epithelium 0.6±0.5 0.8±0.7 1.5±0.5 2.1±0.6 2.3±1.0 
 Lamina propria 0.7±0.6 2.5±3.2 5.6±3.5 7.4±2.7 7.2±3.5 
       
Trachea Epithelium 0.3±0.5 0.8±0.7 0.7±0.5 2.7±1.3 4.3±2.7 
 Lamina propria 1.1±3.1 3.5±4.3 4.5±2.6 5.2±3.5 8.2±5.3 
 
3.4.2 Evolution of FeHV1 mucosal spread  
Mock-inoculated samples (negative controls) did not show any FeHV1 positive cells 
in conjunctival and tracheal mucosa explants throughout the culture period. As shown 
in Figure 1, FeHV1 was found to spread in a plaque-wise manner as the result of 
direct cell-to-cell spread. Individual plaques were visible starting from 24 hpi in 
explant tissues derived from all cats. In the cornea, virus infection was observed at the 
borders of the explants, but plaques were absent in the centers of the explants at all 
time points. The evolution of plaque diameter and penetration depth underneath the 








Figure 1. Confocal photomicrograph of FeHV1 infected feline conjunctiva and trachea 
explants at 24, 48 and 72 h post inoculation (hpi). Collagen VII of the basement membrane 
is stained red; viral antigen positive cells are stained green. Scale bar = 100 µm. 
 
Plaque diameter (Figure 2) - In explant tissues derived from all cats, plaques were 
present in conjunctival and tracheal explants starting at 24 hpi. A statistically 
significant difference in viral plaque diameter was observed between different 
timepoints (P < 0.001) and between the two mucosa explants (P < 0.05). Viral plaque 
diameter did not differ significantly between the three cats (P = 0.138). Viral plaque 
diameter increased significantly over time from 24 hpi (96 ± 30µm) to 48 hpi (194 ± 
60µm) and from 48 to 72 hpi (287 ± 67µm). At 24 and 72 hpi, viral plaque diameter 
did not differ significantly between trachea and conjunctiva (P = 0.33 and 0.98 
respectively). However, at 48 hpi viral plaques in the trachea were on average 38 ± 
15µm wider than in conjunctiva (P < 0.05). 
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Figure 2. Evolution of the mean FeHV1 plaque diameter in conjunctival and tracheal 
mucosa explants at 24, 48 and 72 hpi (3 cats, 10 plaques per cat). Three-way ANOVA, 
followed by Scheffé’s post-hoc test, were performed. Different letters indicate significant 
differences (P < 0.05). Data are represented as mean + SD. 
 
Penetration depth (Figure 3) - Similarly to the viral plaque diameter, a significant 
difference in plaque penetration depth underneath the BM was observed between 
different time points (P < 0.001) and between the two types of mucosa explants (P < 
0.05). No significant difference was found between the three cats (P = 0.120). Except 
for one plaque in a tracheal explant, that penetrated 17µm underneath the BM, no 
vertical spread of virus was observed at 24 hpi. FeHV1 plaques penetrated 21 ± 18µm 
underneath the BM at 48 hpi and 34 ± 21µm at 72 hpi. Plaque penetration depth 
increased significantly over all different time points (all P < 0.05). At 48 and 72 hpi, 
plaques in trachea explants extended on average 13 ± 4µm and 13 ± 6µm further 
underneath the BM than in conjunctiva explants (all P < 0.05). 
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Figure 3. Evolution of the mean FeHV1 plaque penetration depth underneath the BM in 
conjunctival and tracheal mucosa explants at 24, 48 and 72 hpi (3 cats, 10 plaques per cat). 
A Kruskal-Wallis’ test, followed by Mann-Whitney’s post hoc test, were performed. Different 
letters indicate significant differences (P < 0.05). Data are represented as mean + SD. 
 
3.5 Discussion  
In the present study, we described FeHV1 replication in ocular and respiratory 
mucosae during the first 72 hpi using in vitro mucosa explants. Our study shows that 
(i) FeHV1 replicated in conjunctival and respiratory mucosa, but not in the cornea; (ii) 
FeHV1 replicated in a plaque-wise manner and penetrated the BM after 24 hpi. Our 
finding is in line with previous reports in experimentally infected cats. FeHV1 was 
found to preferentially infect and induce necrosis in the conjunctiva rather than in the 
cornea (Nasisse et al., 1989; Townsend et al., 2013). Our study shows that virus 
infection occurred at the edges, but not in the intact center of corneal tissues. This 
suggests that the FeHV1 C27 strain may spread in a cell associated manner from the 
open edges into corneal tissues. Similar to FeHV1, HSV1 exhibits an eye tropism. In 
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vivo studies in mice have shown that some, but not all, HSV1 strains require 
scarification prior to inoculation in order to successfully infect the cornea. 
Non-traumatic inoculation with HSV1, results in viral replication in the conjunctiva, 
but not in the cornea (Kaye et al., 1992; Tullo et al., 1983; Zheng et al., 2001). 
Absence of herpesvirus infection in the intact corneal tissue in the present study may 
be due to several factors. First, the mucins at the cornea surface may hamper the 
attachment of herpesviruses to corneal epithelial cells, in a similar way as they do in 
the respiratory tract (Yang et al., 2012). Secondly, it is possible that receptors are 
absent at the surface of the epithelial cells, leading to a state of resistance. Thirdly, 
viral replication of the FeHV1 C27 strain might be attenuated or modified by passage. 
This could impair its ability to infect the intact cornea. It is known that passage often 
leads to a loss of glycoproteins involved in cell entry, and this could explain the 
apparent inability to infect the cornea, particularly since there is extensive ocular and 
corneal involvement in vivo.  
 
Our data show that FeHV1 crossed the BM more efficiently in tracheal mucosa than 
in conjunctival mucosa. At 48 hpi and 72 hpi, more plaques penetrated the BM in the 
trachea than in the conjunctiva, indicating that the virus requires more time to 
penetrate the BM in conjunctiva. A trypsin-like serine protease, which can degrade 
collagen in the BM, has been demonstrated to mediate penetration of herpesviruses 
through the BM (Glorieux et al., 2011b). Because the BM barriers can vary in 
composition and thickness depending on the tissue/organ, it is possible that the BM of 
the conjunctival mucosa is thicker, more complex and/or has more components, and is, 
therefore, more difficult for virus particles to penetrate (Steukers et al., 2012a). 
Although FeHV1 is phylogenetically most closely related to CaHV1, EHV1 and 
EHV4, they all behave differently in penetrating the BM (Davison, 2002; Gaskell and 
Willoughby, 1999). CaHV1 penetrates the BM in a plaque-wise manner, but more 
slowly than FeHV1 does (unpublished data). EHV1 and EHV4 replication is restricted 
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to epithelial cells. In addition, EHV1 uses monocytic cells and T-lymphocytes as 
“Trojan horses” to transport the virus through the BM (Vandekerckhove et al., 2010; 
Vandekerckhove et al., 2011). FeHV1 exhibited a plaque-wise mucosal spread very 
similar to BoHV1 and PRV, but with smaller plaque diameters and depths than those 
of BoHV1 and PRV (Davison, 2002; Field et al., 2006; Glorieux et al., 2009; Steukers 
et al., 2012b; Vandekerckhove et al., 2010). These different behaviors of 
alphaherpesviruses in their respective hosts are probably the result of a lifelong 
co-evolution. 
  
To our knowledge, this is the first report describing a feline ocular mucosa model, 
consisting of explants. Experimental animal infection models allow studies that are 
close to the field situation, but raise many ethical issues especially in companion 
animals such as cats. The use of an explant model reduces the number of experimental 
animals, and is a compromise between in vitro cell cultures and in vivo laboratory 
animals. Tracheal mucosa explants have previously been used to study FeHV1 
infections (Leeming et al., 2006). However, the viability of these explants was only 
monitored based on the ciliary beating of the epithelial layer. No information was 
available on the viability of the lamina propria. The in vitro model should mimic in 
vivo conditions with an intact BM and viable cells in both epithelial and lamina 
propria for a better understanding of the pathogen invasion. Here, both the ocular and 
respiratory mucosa explants that were kept at an air-liquid interface, were in an 
optimal condition and thus, closely represent the in vivo situation. However, like any 
other experimental models, it has important limitations. First, the explant system can 
only mimic the acute infection within the first 3 days. In addition, the in vitro system 
can only mimic the effects of in vivo local factors. Immunological factors originating 
from blood are absent.  
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Clinically, the ocular disease induced by FeHV1 is very similar to that of herpes 
simplex virus 1 (HSV1). In both cats and humans, naturally occurring primary ocular 
infections consistently cause conjunctivitis, with minimal corneal involvement. 
Primary HSV1 keratitis may appear as multiple scattered microdendritic figures, 
similar to those observed in cats following primary exposure to FeHV1. For both 
FeHV1 and HSV1, infection of the natural host results in a dendritic keratitis that is 
usually self-limiting (AlDujaili et al., 2011; Stiles, 2014; Townsend et al., 2013). 
Based on their similarities, FeHV1 infection of the eyes in cats is a valuable 
homologous model to study herpesvirus-induced ocular diseases in humans. Thus, the 
feline ocular model is ideal to study herpesvirus eye interactions since human ocular 
tissue is difficult to obtain. Especially, this model provides a useful tool for the 
investigation of ocular antiviral drugs.  
 
In conclusion, we successfully developed in vitro feline ocular and respiratory mucosa 
explant models to study FeHV1 invasion at the primary replication sites. FeHV1 did 
not replicate in corneal tissues, but was found to spread in a plaque-wise manner in 
both conjunctival and tracheal tissues. Plaque penetration of the BM started at 24 hpi 
and at 72 hpi most plaques crossed the BM. Furthermore, FeHV1 invaded the BM and 
underlying connective tissue more efficiently in tracheal than in conjunctival mucosa. 
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4.1 Abstract 
Canine herpesvirus 1 (CaHV1) causes a systemic disease in newborn puppies, kennel 
cough at all ages and genital lesions in adult dogs. The aim of the present study was to 
elucidate the viral behavior during the early stage of infection in respiratory and 
genital mucosae, the portals of entry for CaHV1 by the use of ex vivo explants. 
CaHV1 infected and replicated in respiratory and vaginal mucosae in a plaque wise 
manner. CaHV1 started to penetrate the basement membrane (BM) only after 48 h 
post inoculation (hpi) in respiratory mucosal explants, but already after 24 hpi in 
vaginal explants. The plaque latitude and penetration depth increased over time and 
both were larger in the vaginal explants compared to the respiratory mucosal explants. 
The canine respiratory and genital mucosal explants were suitable to study the early 
pathogenesis of CaHV1. CaHV1 showed a better capacity to replicate and invade 
vaginal mucosa compared to respiratory mucosa, based on the latitude and penetration 
depth of the plaques of viral antigen positive cells. 
 
4.2 Introduction 
Canine herpesvirus-1 (CaHV1) is an alphaherpesvirus with a host range, and can 
mainly cause respiratory and genital diseases in dogs (Buonavoglia and Martella, 
2007). CaHV1 is transmitted predominantly through licking, coughing, copulation 
and transplacental spread, and the mucosae of upper respiratory and genital tract are 
important gateways for virus entry (Evermann et al., 2011). Knowledge of the 
pathogenesis CaHV1 is limited. CaHV1 enters and replicates in epithelial cells, then it 
is transported via sensory neuronal axons to the neuronal cell bodies of trigeminal and 
dorsal root ganglia, where it replicates and spreads to neighbouring neurons. 
Thereafter, the virus either establishes a latent infection or is transported back to 
mucocutaneous sites where it is released and replicates, potentially leading to cell 
lysis and the characteristic lesions of a primary CaHV1 infection (Buonavoglia and 
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Martella, 2007). However, little is known about how CaHV1 behaves at respiratory 
and vaginal mucosae. 
 
In order to better understand the primary infection kinetics of CaHV1, we set up an in 
vitro explant model of respiratory and genital tract mucosae derived from bitches to 
mimic the in vivo situation of CaHV1 invasion. 
 
4.3 Materials and methods  
4.3.1 Animals 
Using tissues of euthanized animals is in agreement with the statement of the Local 
Ethical and Animal Welfare Committee of the Faculty of Veterinary Medicine, Ghent 
University. Three female dogs euthanized with phenobarbital (1 mL/1.5 kg; Kela 
Laboratories, Hoogstraten, Belgium) were used as tissue donors with informed owner 
consent. The reason for euthanasia was different from respiratory and genital 
problems. The animals did not show any symptom of respiratory or genital disease. 
Their history of prior exposure to respiratory viruses was not known. Blood was 
collected and examined for CaHV1-specific neutralizing antibodies with the 
complement-dependent seroneutralization test. The ages of the dogs were 5, 7 and 12 
years. The trachea and vagina were isolated immediately after euthanasia. All 
isolation procedures were performed in a laminar flow.  
 
4.3.2 Air-liquid tissue culture 
Canine respiratory and genital mucosal explants were observed and cultivated based 
on a slightly modified protocol as previously described (Steukers et al., 2011). In brief, 
large pieces of trachea and vagina were transferred in a buffered saline solution (PBS), 
supplemented with 1µg/mL gentamycin (Invitrogen, Paisley, UK), 1 mg/mL 
streptomycin (Certa, Braine l’Alleud, Belgium), 1 mg/mL kanamycin (Sigma, St. 
Louis, MO, USA), 1000 U/mL penicillin (Continental Pharma, Puurs, Belgium) and 
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5µg/mL fungizone (Bristol- Myers Squibb, New York, USA) on ice. Next, the vaginal 
mucosa was stripped from the underlying layers. The tracheal mucosa was left on the 
cartilage. Then, tissues were cut into equal pieces with a size of approximately 25mm2. 
All respiratory tissues were observed under a stereomicroscope for cilia beating, and 
only respiratory tissues in which cilia beating was present all over the explants were 
used. Finally, tissues were placed epithelium upwards on sterilized gauzes in 6-well 
plates for culture at an air-liquid interface. The explants were cultured in serum-free 
medium containing 50% DMEM (Invitrogen)/50% Ham’s F-12 Gluta-MAX 
(Invitrogen) supplemented with 0.1 mg/mL streptomycin (Certa), 100 U/mL penicillin 
(Continental Pharma) and 1 µg/mL gentamycin (Invitrogen). Only a thin film of 
medium covered the explants, thereby mimicking the air-liquid interface found in the 
respiratory and genital tract of living animals. All explants were maintained at 37 °C 
and 5% CO2. 
 
4.3.3 Tissue viability 
To determine the viability of the explants, the In Situ Cell Death Detection Kit (Roche 
Diagnostics, Switzerland) was used based on terminal deoxynucleotidyl transferase 
dUTP nick end-labeling (TUNEL), while a Hoechst staining was used to mark cell 
nuclei. The test was performed according to the manufacturer’s guidelines. The 
amount of TUNEL-positive cells was counted from five randomly selected fields of 
100 cells in both epithelium and lamina propria at 0, 24, 48, 72 and 96 h post 
cultivation. All samples were analyzed under a fluorescence microscope (Leica TCS 
SP2 confocal microscopy). 
 
4.3.4 Virus inoculation 
The CaHV1 F205 strain was purchased from ATCC (VR-1785TM). Stock virus was 
propagated in Madin-Darby canine kidney (MDCK) cells. The respiratory and vaginal 
mucosal explants were inoculated with the CaHV1 F205 strain as described for 
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BoHV1 before (Steukers et al., 2012b). Before inoculation, the explants were washed 
twice with PBS in a 24-well microplate (Nunc). Explants were then exposed to 1 ml 
virus suspension containing 106.5 TCID50/mL for 1h at 37°C. After inoculation with 
infectious virus, explants were washed three times and then placed back on the gauze. 
At each examined time point, a mock-inoculated tissue was enclosed. At 0, 24, 48 and 
72 hpi respectively, respiratory and vaginal mucosal explants of each animal were 
collected and embedded in a cryoprotection medium (Methocel®, Fluka (Sigma)) and 
frozen at -70 °C. 
 
4.3.5 Immunostaining 
Consecutive cryosections (20 µm) were fixed in methanol (100%, -20°C) for 20 min. 
To evaluate the spread of CaHV1 in epithelial cells and its penetration depth 
underneath the basement membrane, a double staining was performed. Mouse 
anti-collagen VII antibodies (Sigma) (1:100 in PBS, 1h, 37°C) and goat anti-mouse 
IgG texas red (1:50, 1h, 37°C) were applied to visualize the BM. Afterwards, 
FITC-labeled anti-CaHV1 polyclonal antibodies (VMRD, Pullman, WA, USA) 
(undiluted, 1h, 37°C) were used to visualize virus positive cells in the explants. 
Samples were mounted and analyzed by confocal microscopy (Leica TCS SP2 
confocal microscope). 
 
4.3.6 Statistical analysis 
Data were statistically evaluated by using SPSS software version 20. Normally 
distributed data were analyzed using ANOVA with Tukey post hoc test for 
comparison. The results were presented as means with standard deviation (SD). Data 
that were not normally distributed were analyzed with Mann-Whitney test. A p-value 
of < 0.05 was considered significant. 
 
 




The effect of cultivation on the viability of cells is shown in Table 1. The percentages 
of apoptotic cells in both epithelium and lamina propria were determined at each time 
point of cultivation using confocal microscopy. In the epithelium and lamina propria 
of both tissues, the number of apoptotic cells (TUNEL-positive cells) was slightly, but 
significantly (p < 0.05) increased over time. The percentages of apoptotic cells were 
less than 4% in the epithelium and less than 7% the lamina propria of the explants. 
 
Table 1. Occurrence of apoptosis in epithelium and lamina propria during in vitro culture of 
canine respiratory and genital mucosa explants. TUNEL-positive cells were counted from five 
randomly chosen fields of 100 cells. Values are given as means ± SD. 
 
Tissue Layer % of TUNEL-positive cells at…h post 
cultivation  
0 24 48 72 96 
Respiratory mucosa Epithelium 0.4±0.5 0.7±0.6 0.6±0.5 1.6±0.9 1.8±1.3 
 Lamina propria 0.6±0.6 1.9±2.6 4.3±3.0 5.9±2.6 5.5±3.0 
Genital mucosa Epithelium 0.3±0.4 0.7±0.6 0.7±0.5 2.4±1.4 3.7±2.8 
 Lamina propria 0.4±0.7 2.7±3.3 4.7±2.8 4.1±2.6 6.2±4.5 
SD, standard deviation 
 
4.4.2 Evolution of CaHV1 mucosal spread (Figure 1) 
The respiratory and vaginal mucosal explants of three dogs were inoculated with 
CaHV1 and evaluated at different time point post inoculation. Mock-inoculated 
explants (negative controls) did not show CaHV1 positive cells throughout the whole 
culture period in the respiratory and vaginal mucosae. CaHV1 was found to spread in 
a plaque-wise manner (Figure 1). CaHV1-induced individual plaques were observed 
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starting from 24 hpi in both explants. The evolution of plaque latitude and penetration 
depth underneath the BM could be followed up till the end of the experiment (72 hpi) 
in respiratory mucosal explants, but only up till 48 hpi as almost all epithelial cells in 
the canine vaginal tissues were infected. 
 
Figure 1. Confocal photomicrograph of CaHV1 infected canine respiratory and vaginal 
mucosa explants at 0, 24, 48 and 72 hpi. Collagen VII of the basement membrane is stained 
red; viral antigen positive cells are stained green. Scale bar = 100 µm. 
 
4.4.3 CaHV1- induced plaque latitude (Figure 2) 
The latitude of CaHV1-induced plaques in respiratory mucosal explants increased 
over time with an average of 106.0 ± 43.4 µm at 24 hpi, 138.9 ± 76.3 µm at 48 hpi and 
170.3 ± 119.9 µm at 72 hpi in dog 1 (not significantly different; p = 0.292); an 
average of 70.3 ± 18.6 µm at 24 hpi, 133.6 ± 86.0 µm at 48 hpi and 162.6 ± 50.9 µm 
at 72 hpi in dog 2 (significantly different; p = 0.021); an average of 95.2 ± 67.3 µm at 
24 hpi, 155.4 ± 54.7 µm at 48 hpi and 175 ± 45.8 µm at 72 hpi (significantly different; 
p = 0.01) in dog 3. 
 
In the vaginal mucosal explants, the latitude of CaHV1-induced plaques increased 
significantly (p < 0.001) with an average of 106.7 ± 45.4 µm at 24 hpi and 401.4 
86                                                  Chapter 4 CaHV1 replications in tissue explants 
 
±105.4 µm at 48 hpi in dog 1, 113.6 ± 42.3 µm at 24 hpi and 381.6 ± 108.6 µm at 48 
hpi in dog 2, and 145.9 ± 46.0 µm at 24 hpi and 372.8 ± 102.2 µm at 48 hpi in dog 3. 
Taking together all results, the latitudes of CaHV1-induced plaques in respiratory 
mucosal explants were found to be significantly smaller (p < 0.05) than those in 
vaginal explants at 24 and 48 hpi. 
 
4.4.4 Penetration depth 
The plaque depth underneath the BM was evaluated at 0, 24, 48 and 72 hpi. There was 
a strong difference between respiratory tissues and genital tissues when comparing the 
penetration of the CaHV1-induced plaques through the BM, both in depth and rate.  
In the respiratory mucosal explants, the plaque did not penetrate the BM in all dogs at 
24 and 48 hpi. However, at 72 hpi, 1 out of 10 plaques and 4 out of 10 plaques 
crossed the BM in dog 2 and 3, respectively.  
 
In the vaginal explants, only one plaque had penetrated the BM at 24 hpi whereas at 
48 hpi, 44% of the CaHV1- infected cells plaques crossed the BM in all dogs. The 
average penetration depths in the vaginal explants increased significantly (p < 0.001) 
from 10.4 ± 19.5 µm at 48 hpi to 61.0 ± 13 µm at 72 hpi in dog 1; 38.7 ± 35.6 µm at 
48 hpi to 51.9 ± 17.5 µm at 72 hpi in dog 2; from 3.0 ± 9.0 µm at 24 hpi, 23.2 ± 23.3 
µm at 48 hpi and 63.9 ± 12.9 µm at 72 hpi. 
 
The plaque penetration depth underneath the BM in the three independent 
experiments was significantly higher (p < 0.05) in the vaginal explants than in the 
respiratory mucosal explants at 48 and 72 hpi. 
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Figure 2. Evolution of CaHV1 plaque latitude and plaque penetration depth underneath 
the BM in the respiratory and vaginal mucosa explants at 24, 48 and 72 hpi (3 dogs, 10 
plaques per dog). Data represent the means and standard deviation of three independent 
experiments. Asterisks (**) indicate a significant difference between both types of explants. 




Our study showed that plaque latitudes increased faster in the vaginal tissues than in 
the respiratory mucosal tissues between 24 and 48 hpi. This is similar to bovine 
herpesvirus 1 (Steukers et al., 2011), and can be explained by several reasons. Firstly, 
the vaginal tissues are less capable of generating local mucosal responses of the innate 
immunity compared to respiratory tissues (Russell and Mestecky, 2002). Secondly, 
the epithelial cell type and intercellular connections are different in these two different 
mucosae. The main cells of the respiratory epithelium are ciliated cells, which are of 
narrow columnar type (Pack et al., 1980). The main cells of the vaginal epithelium are 
squamous (Moll et al., 1983). Thus, more cells are present within the same area in the 
respiratory epithelium compared to the vaginal epithelium. When one considers one 
replication cycle and transmission to neighbouring cells every 12 h, a smaller area 
will be infected in respiratory mucosal explants than in vaginal explants. In addition, 
the stratified squamous epithelial cells of the vaginal mucosa are connected with more 
robust junctions than the ciliated epithelial of cells of the respiratory mucosa 
(Blaskewicz et al., 2011). These robust junctions may facilitate the cell-associated 
spread of the virus (Nauwynck et al., 2007). 
 
In the vaginal mucosa, the replication characteristics of CaHV1 were similar to that of 
BoHV1, but both spread slower than HSV1/-2 in the stratified epithelium. In addition, 
HSV1/-2 induced prominent epithelial syncytia, which were not observed with 
CaHV1 or BoHV1 (Steukers et al., 2011; Steukers et al., 2014). The formation of 
syncytia in human tissues might be an example of co-evolution of human herpesvirus 
with their host. CaHV1 and BoHV1 have a better capacity to cross the BM of the 
vaginal explants compared to HSV1/2. In the near future, the underlying mechanism, 
which may give an explanation for this difference, will be elucidated. 
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CaHV1 is genetically closely related to feline herpes virus 1 (FeHV1), but unlike 
CaHV1, FeHV1 seldom induces reproductive problems (Thiry et al., 2009). Recent 
experiments with feline vaginal explants have demonstrated that upon FeHV1 
inoculation plaques are formed which rarely penetrate the BM (unpublished data). 
The present study shows that CaHV1 had a main tropism for the genital epithelium, 
which agrees with in vivo findings with CaHV1-induced vesicles and ulcerations in 
the genital tract (Evermann et al., 2011).  
 
In conclusion, ex vivo canine respiratory and genital mucosa explants were 
established, enabling research on CaHV1 replication and invasion. CaHV1 spreads in 
a plaque wise manner, and has a better tropism for genital than for respiratory tissues. 
Researchers may use these CaHV1 explant models to develop antiviral and safe 
attenuated vaccines in a research based way. 
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5.1 Abstract 
In the upper respiratory tract, the basement membrane (BM) is a barrier underlying 
the epithelial cell layer which is crossed during the invasion of alphaherpesviruses. 
Pseudorabies virus (PrV) directly breaches the BM barrier, which involves a serine 
protease. Here, we examined if the plasminogen activator-plasmin system, an 
enzymatic cascade for BM degradation, which is coordinated by serine proteases, is 
involved in the process of PrV BM penetration. In this study, porcine nasal mucosa 
explants were infected by pseudorabies virus. Immunofluorescence staining of 
porcine respiratory explants revealed that plasminogen and plasmin were present. 
Various forms of plasminogen and plasmin were found in porcine respiratory explants 
as demonstrated by Western blot. Plasmin was expressed in the epithelial virus plaque 
starting from 24 hours post inoculation (hpi) in porcine nasal mucosa explants. 
Further, the urokinase plasminogen activator (uPA) inhibitor WX-340 and the plasmin 
inhibitor tranexamic acid (TXA) were evaluated for their potential to inhibit the 
invasion of three pseudorabies virus (PrV) strains: NS374 (1971), 75V19 (1975) and 
89V87 (1989). The penetration of the BM by NS374 and 75V19 was inhibited by both 
inhibitors, whereas 89V87 was significantly inhibited by TXA and only to a very 
limited extent by WX-340. These data revealed a clear role of the plasminogen 
activator-plasmin system in PrV invasion. 
5.2 Introduction 
Alphaherpesviruses use the upper respiratory mucosa for their primary replication and 
subsequent invasion. The passage of the virus through the basement membrane (BM) 
is a prerequisite for a successful host invasion (Steukers et al., 2012a). 
Alphaherpesviruses use different strategies to cross the BM in order to reach the 
underlying lamina propria. Some of alphaherpesviruses, including herpes simplex 
virus 1 (HSV1), pseudorabies virus (PrV), bovine herpesvirus 1 (BoHV1), feline 
herpesvirus 1 (FeHV1), and canine herpesvirus 1 (CaHV1) directly penetrate through 
the BM (Glorieux et al., 2011a; Glorieux et al., 2007; Li et al., 2016; Li et al., 2015; 
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Steukers et al., 2012b). Glorieux et al. (2011b) demonstrated that PrV crosses the BM 
by the use of a trypsin-like serine protease. In this study, the serine protease AEBSF 
inhibited the viral penetration through the BM. Further study using the Soybean Type 
I-S trypsin inhibitor of trypsin-like serine proteases, one of the serine protease 
subcategories, revealed the involvement of a trypsin-like serine protease in the PrV 
invasion process through the BM. Several cellular components associated with 
trypsin-like serine protease activity are differentially regulated upon infection with 
HSV1, including tissue-type plasminogen activator (tPA), urokinase plasminogen 
activator receptor (uPAR) and factor IX (Blanchard et al., 2006; Ray and Enquist, 
2004). These cellular components are involved in the plasminogen activator-plasmin 
system (Stewart and Sayers, 2013).  
 
The plasminogen activator-plasmin system contains the inactive proenzyme 
plasminogen, which is transformed into the proteolytically active plasmin mainly by 
two plasminogen activators, uPA and tPA (Syrovets and Simmet, 2004). uPA is an 
activator of extracellular proteolysis, and is involved in cell apoptosis, migration and 
proliferation (Collen and Lijnen, 1995; Plow et al., 1995). tPA facilitates fibrin 
break-down (Syrovets and Simmet, 2004). In general, plasminogen activation is more 
related to tissue damage and subsequent repair mechanisms than to specific 
pathological situations (Kramer et al., 1995). Epithelial cells release plasminogen 
activators which generate plasmin from plasminogen. Activation of the plasminogen 
activator-plasmin system leads to the degradation of both fibrin and fibronectin, as 
well as the laminin component of the BM (Berman et al., 1983). Due to these 
potential damaging activities, plasmin activity must be well regulated by the host.  
 
The plasminogen activator-plasmin system may play a crucial role during pathogen 
infection. Plasminogen activation is tightly regulated by the balance between 
plasminogen activators tPA and uPA and their principal inhibitors-1 and 2 (Pepper, 
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2001). The balance may be broken by the entrance of pathogens into the epithelial cell. 
By doing this, plasmin may help the pathogen to cross the BM by degrading this 
barrier. Afterwards, the pathogen may disseminate to internal target organs. It has 
already been reported that HSV1 and 2, and cytomegalovirus (CMV) accelerate the 
proteolytic activation of plasminogen to plasmin by tPA (Gershom et al., 2012). 
Another human herpesvirus, Epstein-Barr virus (EBV), regulates uPA expression in 
tumors (Nakada et al., 1999). Induction or upregulation of the plasminogen 
activator-plasmin system in the upper respiratory mucosa during an alphaherpesvirus 
infection has not been reported yet. Whether this system can be activated during the 
viral-mucosa interaction and results in viral BM penetration is examined in the 
present study.  
 
5.3 Materials and methods 
5.3.1 Viruses 
Three different Belgian PrV strains were used in this study. NS374, a mild PrV strain, 
and 75V19, a virulent PrV strain, were isolated from the brains of pigs with nervous 
symptoms in the 1970s. 89V87, a highly virulent PrV strain, was isolated in 1989 
from an aborted foetus. All PrV strains were propagated in porcine testicle (ST) cells 
for 2 passages.  
 
5.3.2 Ex vivo respiratory mucosa explant system  
Porcine nasal mucosa explants were generated as previously described (Glorieux et al., 
2009). At 24 h after cultivation, explants were placed in a 24-well plate and washed 
twice with warm medium. After 1h incubation with 1 ml inoculum containing 106.0 
TCID50/ml of PrV, explants cultivated at 37 °C and 5% CO2. The explants were 
collected at 0, 24, 48 and 72 hpi and embedded in a cryoprotection medium 
(Methocel®, Fluka, Sigma) and frozen at -70 °C. 
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5.3.3 Western blot analysis of plasminogen and plasmin 
SDS-PAGE and Western blot analyses were performed essentially as described 
previously (Setas Pontes et al., 2015). Briefly, porcine respiratory mucosa explant 
tissues were first homogenised. A loading buffer with the sample and the anionic 
detergent sodium dodecyl sulfate (SDS) was boiled at 100°C for 5 min to denature. 
Samples were run on a 12% polyacrylamide gel. After electrophoresis, the separated 
proteins were electroblotted onto nitrocellulose membranes. Blots were blocked for 60 
min in a blocking solution (5% nonfat dry milk in PBS-Tween 20), and were 
subsequently incubated overnight with goat anti-plasminogen/plasmin antiserum 
(1:500; antibodies-online GmbH, Aachen, Germany). Following three washes with 
Tris-buffered saline, the membrane was incubated with rabbit anti-goat 
immunoglobulin HRP secondary antibody (1:3000, Dako, Denmark) for 1 h. Bovine 
plasminogen (biopur, Switzerland) was used as a positive control. The results were 
visualized with an ECL Western blot detection system (GE Healthcare).  
 
5.3.4 Inhibitor assays in explants 
We used tranexamic acid (TXA) as plasminogen inhibitor, which acts by 
competitively blocking the lysine binding sites of plasmin(ogen), thereby preventing 
binding to fibrin or cells (Dunn and Goa, 1999). WX-340, a highly specific and 
selective inhibitor of uPA, was also evaluated in this study (Endo-Munoz et al., 2015). 
At 24 h after cultivation, explants were placed in a 24-well plate and washed twice 
with warm medium. The explants were inoculated with 1 ml medium containing 106.0 
TCID50/ml of PrV strains 89V87, 75V19 or NS374 for 1 h at 37 °C and 5% CO2. At 1 
hour post inoculation (hpi), explants were washed twice with warm medium and were 
immersed for 1 h in medium with or without inhibitor. In this assay, WX-340 was 
used at concentrations of 10, 30 and 100 µM, and TXA was used at concentrations of 
1, 3 and 10 mM. Then, explants were transferred back from the 24-well plate to their 
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gauze with medium with or without the inhibitor. The ciliary beating of explants was 
checked on a daily basis using an Olympus CK40 light microscope. 
 
5.3.5 Immunofluorescence stainings  
To detect the distribution of plasmin(ogen) in porcine respiratory explants, 
cryosections were incubated with goat anti-plasminogen/plasmin antiserum (1:100 in 
PBS, 1 h, 37 °C), followed by FITC-labelled rabbit anti-goat IgG antibodies (1:100 in 
PBS, 1 h, 37 °C. Cell nuclei were counterstained with Hoechst 33342 (Molecular 
Probes) (1:100 in PBS) at 37 °C. The cryosections were mounted with 
glycerin-DABCO (Janssen Chimica, Belgium) after washed with PBS. 
 
To detect the activated plasmin in PrV- infected explants, cryosections of PrV- 
infected explants were made and fixed in methanol (-20 °C, 100%) for 20 min. After 
washing, virus-infected cells were detected using FITC-labeled porcine polyclonal 
anti-PrV antibodies (Nauwynck and Pensaert, 1995) (1:100 in PBS, 1 h, 37 °C). Then, 
plasmin in explants was detected using the chromogenic substrate CS-41(03) 
(L-pyroglutamyl-L-phenylalanyl-Llysine-p- nitroaniline hydrochloride, HYPHEN 
BioMed, Neuville-sur-Oise, France) by monitoring the signal of p-nitroaniline release 
at 405 nm (1:1 in PBS, 5 min, 37 °C). Finally, cryosections were washed three times 
with PBS and mounted with glycerin-DABCO (Janssen Chimica, Belgium). 
 
To evaluate the effect of inhibitors in explants, the following immunofluorescence 
staining was performed. Mouse anti-collagen VII (Sigma) (1:100 in PBS, 1 h, 37 °C) 
and goat anti-mouse IgG Texas Red (1:100 in PBS, 1 h, 37 °C) were used for the BM 
visualization. Next, PrV-infected cells were detected by FITC-labeled porcine 
polyclonal anti-PrV antibodies (1:100 in PBS, 1 h, 37 °C). Finally, after washing, the 
sections were incubated with Hoechst 33342 (1:100 in PBS) for 10 min. The 
cryosections were mounted with glycerin-DABCO (Janssen Chimica, Belgium).   
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5.3.6 Confocal microscopy imaging and plaque analysis  
Series of immunofluorescent stained cryosections were analyzed using an SPE 
confocal microscope (Leica Microsystems GmbH, Heidelberg, Germany). For each 
condition, maximal plaque size and depth underneath the BM were measured for 10 
plaques; triplicate independent experiments were performed. The plaques at the lateral 
and bottom edges of the explants were excluded from analysis. 
 
5.3.7 Statistical analysis  
Data are presented as means ± standard error of mean (SEM). Statistical analysis was 
performed with one-way ANOVA using GraphPad Prism 5.0 software. Since viral 
plaque penetration depth data were heteroscedastic after log-transformation, a 
Kruskal-Wallis’ test followed by Mann-Whitney’s post-hoc test was performed. A 
value of P<0.05 was considered to indicate a statistically significant difference. 
 
5.4 Results  
5.4.1 Detection of the plasminogen activator-plasmin system in porcine nasal mucosa 
explants 
Plasminogen was found in respiratory epithelium, lamina propria and gland of porcine 
respiratory explants (Figure 1A). Different molecular forms of plasminogen and 
plasmin were detected by Western blot (Figure 1B). Under reducing conditions, 
Glu-plasminogen and Lys-plasminogen were detected in both virus infected and 
non-infected explants. Plasmin gave three bands corresponding to molecular masses 
of 68, 46 and 23 kDa, which correspond with the molecular weights of Glu-plasmin 
heavy chain, Lys-plasmin heavy chain, and plasmin light chain. In addition, two 
additional bands between 100 and 200 kDa appeared in most of the samples except in 
samples from 89V87 infected explants; a band with a molecular weight of 
approximately 30 kDa appeared in some samples. 













Figure 1. Detection of plasminogen/plasmin in porcine respiratory explants. 
Immunofluorescence staining of porcine respiratory explants (A) showing the distribution of 
plasmin(ogen) (green) in the porcine respiratory mucosa explants. Nuclei were 
counterstained blue with Hoechst. Scale bar = 100 µm. Western blot analysis of 
plasminogen/plasmin at 0, 24 and 36 hours post inoculation (hpi) of porcine respiratory 
mucosa explant with PrV (B). Proteins from porcine respiratory mucosal explants were 
submitted to SDS-PAGE and Western blot. Plasminogen and plasmin were revealed with goat 
anti-plasminogen/plasmin serum and rabbit anti-goat immunoglobulin HRP secondary 
antibody. a=Glu-plasminogen; b=Lys-plasminogen; c=Glu-plamin heavy chain; 
d=Lys-plasmin heavy chain; e=plasmin light chain.   
 
5.4.2 Detection of plasmin in PrV plaques of porcine nasal mucosa explants 
By the use of plasmin substrate and immunofluorescence staining, plasmin was 



















Figure 2. Representative confocal microscopic images of active plasmin in viral-induced 
plaques in porcine respiratory mucosa explants at 24 hpi. Images for the individual channels 
are shown from left to right (green fluorescence, PrV viral antigens; blue fluorescence, active 
plasmin signal; overlay of viral antigens with active plasmin signal). White dotted line 
represents the BM. Scale bar = 100 µm.  
 
5.4.3 The effect of uPA/plasmin inhibitors on PrV invasion through the BM 
Morphometric analysis of the kinetics of PrV spread in nasal mucosa explants was 
previously performed (Glorieux et al., 2009). In the present study, the effect of uPA 
and plasmin inhibitors on PrV invasion of the BM was evaluated in porcine nasal 
mucosa explants at 24 hpi. PrV replicated in a plaque-wise manner in inhibitor treated 
and mock-treated explants (Figure 3).  
 
Viral antigen           Plasmin              Overlay 




Figure 3. Confocal photomicrographs showing PrV (89V87 strain) plaques in (A) 
non-inhibitor treated and (B) plasmin inhibitor-treated (10 mM of TXA) porcine nasal 
mucosa explants at 24 hpi. Green fluorescence visualizes PrV antigens; collagen VII 
(component of the basement membrane) is stained with Texas Red; blue fluorescence 
represents cell nuclei. Figure A shows a viral plaque crossing the BM. Figure B illustrates 
the blocked viral invasion underneath the BM in the presence of the plasmin inhibitor TXA. 
Scale bar = 100 µm.  
 
The plaque diameters of inhibitor-treated explants did not differ significantly with 
non-treated explants. In NS374 inoculated explants, a dose-dependent decrease in the 
plaque depth underneath the BM was observed with the uPA inhibitor WX-340 (10 
µM- 60% reduction, 30 µM- 88% and 100 µM- 98%) and the plasmin inhibitor TXA  
(1 mM- 62%, 3 mM- 94% and 10 mM- 100%) (Figure 4). Incubation of PrV 75V19 
inoculated explants with WX-340 at 10, 30 and 100 µM resulted in a 41%, 83% and 
100% reduction in penetration depth underneath the BM, and with TXA at 1, 3 and 10 
mM in a 45%, 88% and 96% reduction (Figure 4). WX-340 reduced the plaque depth 
of 89V87 strain with 31% at 10 µM, 23% at 30 µM, 31% at 30 µM. When using TXA 
at 1, 3, and 10 mM, the inhibitor reduced the plaque depth underneath the BM by 43%, 
86% and 93%, respectively (Figure 4). 
A B 




Figure 4. Plaque diameter and penetration depth underneath the basement membrane (BM) 
of plaques induced by different PrV strains at 24 hpi. Data are represented as means of 10 
plaques of triplicate independent experiments ± SEM (error bars). The percentages of 
reduction are relative to the mock treated group, which was set at 100%. Significant 
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differences are pointed out by the use of different numbers of * and #. Plaque diameter 
groups revealed no apparent differences with the mock groups. WX-340 had a strong 
inhibitory effect on the spread of PrV NS374 and PrV 75V19, and a minor effect on the 
spread of PrV 89v87. TXA strongly inhibited the penetration of the three PrV strains. 
 
5.5 Discussion 
It is well known that plasmin plays a significant role in the degradation of BM 
components (Liotta et al., 1981). The plasminogen activator-plasmin system is well 
studied in blood vessels and skin, occasionally in some internal organs (Li et al., 
2003). Previous studies have demonstrated the presence of uPA and their receptors 
and inhibitors in the upper respiratory tract, and tPA has only been demonstrated in 
nasal polyps so far ( Stevens et al., 2015; Stewart and Sayers, 2013). Here, the 
presence of plasminogen/plasmin in the upper respiratory tract has been confirmed for 
pigs. Various forms of plasminogen/plasmin were found in the respiratory mucosa. 
We can conclude that the plasminogen activator-plasmin system exists and 
presumably can be activated in porcine respiratory explants, although it is hard to 
distinguish the different forms in situ.  
 
In viral infected explants, unpredicted bands were detected by Western blot analysis. 
These unexpected bands could be proteins that are related to plasminogen, such as 
angiostatin and mini-plasmin. Both angiostatin and mini-plasmin are fragments of 
plasmin. Angiostatin contains 1-4 kringles of plasminogen, and plays a role in 
plasmin generation in tumors (Cao and Xue, 2004). Mini-plasmin is related to 
respiratory disorders (Murakami et al., 2001). So far, involvement of these proteins in 
the pathology of PrV has not been described yet.  
 
Previously, a quantitative analysis of the kinetic evolution of PrV replication in 
porcine respiratory mucosa explants was evaluated (Glorieux et al., 2008). PrV 
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spreads in a plaque-wise manner and penetrates through the BM barrier between 12 
and 24 hpi. PrV 89V87 strain was found to penetrate through the basement membrane 
around 16hpi (Glorieux et al. 2011b). Therefore, PrV BM crossing was analyzed 
starting from 24hpi.   
 
Our study demonstrated that both the uPA inhibitor WX-340 and plasmin inhibitor 
TXA strongly reduced the plaque depth of the PrV NS374 and 75V19 strains 
underneath the BM in nasal mucosa, whereas only the plasmin inhibitor had a strong 
effect on the invasion of the 89V87 strain. Although speculative, a possible 
explanation may be that there are two pathways leading to plasmin activation that 
digests the BM afterwards: (i) indirectly via an upregulation of uPA expression and/or 
activation and (ii) directly upon contact with plasminogen. According to our findings, 
it seems that NS374 and 75V19 mainly activate the system by uPA, whereas 89V87 
may directly convert plasminogen into plasmin. In addition, we further detected that a 
more recent PrV strain 00V72 can be inhibited by the plasmin inhibitor TXA, but not 
by the uPA inhibitor WX-340 (data not shown). Some older strains (NIA1, NIA3) can 
be inhibited by both the uPA inhibitor and the plasmin inhibitor (data not shown). 
Although additional experiments are needed to substantiate this, these results may 
possibly aid in explaining the increased virulence of PrV over the past decades. 
 
The synthetic plasmin inhibitor TXA was used in this study. TXA blocks the lysine 
binding sites of plasminogen, which prevents the activation of plasminogen (Ollier et 
al., 2004). TXA is a cheap medicine that is available worldwide with proven efficacy 
in reducing blood loss. A high concentration (1 to 10 mM) of TXA was used in our 
study, which is equal with that used on cells by Ollier et al. (2004). In this study, 
influenza virus replication was reduced by TXA (Ollier et al., 2004). In vivo, a high 
concentration could only be reached during continuous intravenous infusion (Goobie 
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et al., 2013). Because pigs are difficult to restrain, oral drugs should be developed for 
in vivo use. 
 
Based on the present work, it can be concluded that the plasminogen activator- 
plasmin system exists in the porcine respiratory mucosa. During PrV infection of the 
respiratory mucosa, the system is activated, resulting in the viral BM penetration, 
thereby enhancing the viral penetration of the BM. The uPA inhibitor WX-340 
strongly inhibited the spread of PrV NS374 and PrV 75V19, but not 89V87, while the 
plasmin inhibitor TXA strongly inhibited the penetration of all the three PrV strains.  
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Alphaherpesviruses, a subfamily of the Herpesviridae, typically infect mucosal 
surfaces. Alphaherpesviruses replicate initially in the epithelial cells of the mucosae, 
after which they cross the basement membrane barrier and replicate and spread in the 
lamina propria underneath. Further, the virus may spread to some internal organs such 
as the central nervous system and pregnant uterus via lymph, blood and nerves. Viral 
replication at the mucosae and further spread may lead to respiratory, ocular and 
genital problems, nervous disorders and reproduction failures (Zaichick et al., 2011). 
The replication kinetics and invasion mechanism at the primary replication sites are 
not fully understood. In order to find novel treatment strategies, a better understanding 
of these parts of the pathogenesis is important. Although alphaherpesviruses are 
closely related, the replication and invasion strategies of these viruses at their primary 
entry sites differ to some extent. Previous research has shown that pseudorabies virus 
(PrV) directly penetrates the basement membrane in a plaque-wise manner, and that 
proteases mediate viral spread across the basement membrane (Glorieux et al., 2011b). 
BoHV1 also displays a plaque-wise spread during its dissemination in both respiratory 
and genital mucosae explants; it crosses the basement membrane more efficiently in 
the respiratory tract than in the genital tract (Steukers et al., 2011). Similar findings 
were also observed with HSV1 (Glorieux et al., 2011a; Steukers et al., 2014). HSV2 
also exhibited a plaque-wise manner to across the basement membrane and induced 
prominent epithelial syncytia in genital tissues (Steukers et al., 2014). The invasion of 
EHV1 is quite different. EHV1 does not replicate in the lamina propria but infects 
resident immune cells in the epithelial cell layer and misuses their motile nature to 
invade the host (Vandekerckhove et al., 2010). EHV4 only replicates respiratory 
epithelium, and lacks the ability to cross the basement membrane (Vandekerckhove et 
al., 2011). These findings highlight the different strategies used by herpesviruses to 
cross the basement membrane barrier. Besides respiratory and genital mucosae, the 
ocular mucosa may be an important primary infection site for alphaherpesviruses, e.g. 
FeHV1. The current thesis first studied the mucosal invasion characteristics of FeHV1 
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and CaHV1 via newly established ocular, respiratory and genital explant models. 
These studies gave new insights in the interaction of FeHV1/CaHV1 with mucosae 
and were complementary with similar work that had been performed with other 
alphaherpesviruses (PrV, HSV1, BoHV1, EHV1) in the laboratory of the promoter. 
Additionally, the invasion mechanism of PrV was investigated in more detail. 
 
In vitro tissue culture of ocular, respiratory and genital mucosae of feline and 
canine origin  
In the present thesis, we have evaluated feline ocular and respiratory and canine 
respiratory and vaginal explant models to elucidate the interactions between 
FeHV1/CaHV1 and their host mucosae. Ex vivo tissue cultures are an elegant, 
reproducible and physiologically relevant compromise between in vivo and in vitro 
models. The use of an explant model can avoid sacrificing large numbers of 
experimental animals, which contributes to the important ethical dogma: Refinement, 
Reduction and Replacement (3R principle). In addition, the explant models allow a 
3D viral infection, which is much more relevant than the 2D infection in monolayers 
of cell cultures because it mimics the in vivo situation. Characteristics of living tissues 
that are important for their function are cell-ECM interactions and cell-cell contacts 
(Page et al., 2013).  
 
Feline and canine respiratory mucosae explants were already described before. They 
were used to study FeHV1 and bacterial infections (Anderton et al., 2004; Leeming et 
al., 2006). However, in these studies, the viability of the cell was not evaluated, and 
the integrity of the lamina propria and submucosa was not assessed during inoculation. 
To compare the infection kinetics of herpesviruses in respiratory and genital explants 
from different species, ex vivo explant models were developed consisting of 
respiratory and genital mucosae of horses, pigs, cattle, chicken and humans following 
a standardized way in the promoter’s research team (Glorieux et al., 2007; Glorieux et 
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al., 2011a; Reddy et al., 2014; Steukers et al., 2012; Steukers et al., 2014; 
Vandekerckhove et al., 2009). In general, these explants are cultivated at 37 °C, 5% 
CO2, in serum-free conditions and can be maintained for 3 to 4 days. The viability of 
different cells did not significantly decrease over time. The use of similar culture 
conditions allows to compare the replication characteristics of different 
alphaherpesviruses. 
 
Alphaherpesvirus FeHV1 and CaHV1 invasion characteristics in different 
mucosae 
The alphaherpesvirus FeHV1 is the causal agent of conjunctivitis, keratitis and 
rhinotracheitis. FeHV1 is highly host specific. Although FeHV1 is well-known to 
cause ocular and respiratory problems, the underling pathogenesis during primary 
infection remains poorly understood. In Chapter 3, we determined the replication 
kinetics of FeHV1 and the viral primary invasion in the mucosae of their natural host, 
the cat. FeHV1 virus infection occurred at the edges, but not in the intact center of 
corneal tissues. Absence of herpesvirus infection in the intact corneal tissue in the 
present study may be due to 1) the mucins at the cornea surface that may hamper the 
attachment of herpesviruses to corneal epithelial cells; 2) absence of receptors at the 
surface of the epithelial cells, leading to a state of resistance; 3) 
attenuation/modification of the FeHV1 C27 strain during passaging. This finding 
suggests that FeHV1 seems to exhibit a higher affinity for the conjunctiva than for the 
cornea, and that FeHV1 may spread in a cell associated manner from the open edges 
into corneal tissues during the initial infection. FeHV1 infection of ocular explants 
may be a valuable model for ocular HSV1 infection studies, since the ocular disease 
induced by FeHV1 is quite similar to that of HSV1 (Maes, 2012). Clinically, the 
primary infection of HSV1 is usually a nonspecific self-limiting conjunctivitis, often 
in early childhood and usually without corneal involvement (Azari and Barney, 2013). 
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In Chapter 3, we showed that feline conjunctival mucosa and tracheal mucosa 
explants are susceptible to FeHV1 infection. In both conjunctival and tracheal tissue, 
the virus was able to quickly disseminate in a plaque-wise manner and invade by 
breaching the basement membrane barrier. This clearly shows that the virus is well 
adapted to disseminate within conjunctival and tracheal mucosae. This potent invasive 
capacity in these tissues may explain why ulceration and osteolytic changes in the 
turbinate bones are part of the clinical entity caused by FeHV1.  
 
The alphaherpesvirus CaHV1 infects the respiratory tract and reproductive organs of 
dogs. In Chapter 4, we established canine respiratory and genital mucosae explant 
models to study CaHV1 infection. CaHV1 spreads in a plaque-wise manner in both 
respiratory and genital explant models, and has a better tropism for genital than for 
respiratory tissues. When comparing the replication kinetics of CaHV1 in different 
tissues, CaHV1 plaques were found to have a bigger plaque diameter in vaginal 
epithelium compared to plaques in tracheal epithelium. This trend has also been 
observed for BoHV1 and HSV1 in respiratory and genital tissues (Glorieux et al., 
2011a; Steukers et al., 2011; Steukers et al., 2014). This might be due to differences in 
local mucosal immune responses between vaginal and tracheal tissue or the different 
cell types and intercellular connections between vaginal and tracheal epithelial cells 
(Blaskewicz et al., 2011; Nauwynck et al., 2007).  
 
In Chapter 4, it was found that CaHV1 can spread efficiently in the depth in vaginal 
tissues. CaHV1 replication in the vaginal mucosa is associated with clinical symptoms, 
as it causes vaginal lesions under natural conditions. When we combine the clinical 
reports with our findings, we could propose that in pregnant dogs, localized genital 
lesions occur at the site of viral inoculation after initial exposure. As a result, puppies 
may become infected during delivery when passing the vagina. This represents an 
important transmission route from pregnant bitches to puppies at birth. 




Different replication kinetics and dissemination of alphaherpesviruses in mucosae can 
be linked with differences in clinical symptoms. The highly invasive PrV, BoHV1 and 
FeHV1 have the power to cause severe acute respiratory distress. In contrast, CaHV1, 
EHV1 and EHV4, which lack the ability to penetrate plaque-wise through the 
basement membrane in the respiratory tissue, only cause mild respiratory problems.  
 
FeHV1 and CaHV1 are genetically closely related (Gaskell et al., 2007), however 
their clinical behaviors differ significantly in genital tissues. FeHV1 seldomly induces 
reproductive lesions while CaHV1 may cause reproductive problems (Thiry et al., 
2009). Recent experiments with feline vaginal explants have demonstrated that upon 
FeHV1 inoculation, plaques are formed which rarely penetrate the basement 
membrane although the virus can easily spread laterally (unpublished data). Our data 
indicate that CaHV1 shows a main tropism for the genital epithelium and is able to 
cross the basement membrane, which appears to be in line with the findings in vivo 
(Evermann et al., 2011). Compared with FeHV1, CaHV1 showed a more restricted 
replication in respiratory explants. This is also in accordance with the in vivo findings, 
since respiratory signs of CaHV1 infection are less severe or absent compared to those 
following infections with FeHV1. The capacity of alphaherpesviruses to penetrate 
through the basement membrane may vary depending on the mucosa (conjunctival, 
respiratory and genital), host and viral species. The underlying mechanism is still not 
clear. Because CaHV1 causes a serious systemic fatal heamorrhagic disease in 
puppies, we predict that the virus may penetrate the basement membrane in the upper 
respiratory tract early in life. It is not clear if this occurs via a local destruction of the 
basement membrane or if leukocytes are used as invasion vehicles. 
 
In conclusion, mucosa explant models were developed to study virus-mucosa 
interactions. These ex vivo models enable the evaluation of the kinetic evolution of the 
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horizontal and vertical spread of feline/canine alphaherpesviruses in the mucosa, 
which is close to the in vivo situation. With the rapid development of genome 
sequencing technology, more information will be available for animal 
alphaherpesviruses research. Comparing tissue tropism of different alphaherpesvirus 
strains and their genomic backgrounds can provide more insights in the invasion 
mechanism of alphaherpesviruses.  
 
The plasminogen activator-plasmin system is involved in the plaque-wise 
crossing of the basement membrane by PrV 
In Chapter 3 and 4, we described that FeHV1 plaques cross the basement membrane 
in conjunctiva and trachea explants at 48 hpi, and CaHV1 penetrates the basement 
membrane in vaginal explants at 48 hpi. Similar observations were described for PrV 
in respiratory mucosa explants at 16 hpi (Glorieux et al., 2011b). We were interested 
in which cellular effectors are involved in the viral invasion mechanism. During 
previous work in the laboratory of the promoter, it was found that a trypsin-like serine 
protease is involved in PrV penetration of the basement membrane, and it was 
indicated that the plasminogen activator-plasmin system might be involved in this 
process (Glorieux, 2009; Glorieux et al., 2011b). 
 
In Chapter 5, plasminogen and plasmin were detected in the porcine respiratory 
mucosa using Western blot and immunostainings. Since other components of the 
plasminogen activator-plasmin system such as uPA their receptors and inhibitors are 
also described in these tissues, and tPA has been demonstrated in nasal polyps (; 
Stevens et al.2015; Stewart and Sayers, 2013), we believed that the plasminogen 
activator-plasmin system exists in the mucosa and is kept at a dynamic equilibrium.  
 
Swine respiratory explants were first treated with uPA or plasmin inhibitors, followed 
by inoculation with different virulent strains of PrV. The penetration of the basement 
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membrane by two older PrV strains was inhibited by both inhibitors, whereas a more 
recent strain 89V87 was only inhibited by the plasmin inhibitor. Therefore, depending 
on the virus strain, plasmin that digests the basement membrane may be activated 
indirectly via an upregulation or activation of uPA or directly upon contact with 
plasminogen. Plasmin inhibitors may be the most suitable candidates to inhibit PrV 
invasion through the basement membrane.  
 
In Chapter 5, the synthetic plasmin inhibitor TXA was used to inhibit PrV invasion. 
PrV is a cofactor of the porcine respiratory disease complex (PRDC). The most 
common agents involved in PRDC include viral and bacterial pathogens (Thacker, 
2001). An important viral agent, influenza virus, enhances plasmin generation during 
respiratory infection (Kido et al., 1999; Windeyer et al., 2012). A preliminary 
experiment in our lab demonstrated that plasmin inhibitor TXA can limit influenza 
virus replication in the porcine respiratory mucosa explant model (unpublished data). 
In addition, many bacteria can stimulate plasminogen activation (Bhattacharya et al., 
2012). Plasmin inhibitors may inhibit such plasmin generation. Thus, these plasmin 
inhibitors may have a potential as drugs to interfere with PRDC.  
 
Hypothesis   
We have found that the cellular components uPA and plasmin are associated with 
alphaherpesvirus penetration through the basement membrane. However, the viral 
proteins that are involved in this process are still not identified. Recent studies in our 
department demonstrated that a US3 deleted PrV mutant has a limitation to penetrate 
the basement membrane (Lamote et al., 2016). Because US3 encodes a 
serine/threonine protein kinase (PK) (Jung et al., 2011), and uPA expression is 
normally regulated by cellular serine/threonine protein kinases (Leslie et al., 1990; 
Witowsky et al., 2003), it could be that in the viral infected cells, the viral US3 PK 
stimulates cells to express and secrete uPA, resulting in activation of plasminogen. 
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uPA plays an important role in this pathway, thus old strains (75V19 and NS374) 
might mainly use this pathway to activate plasminogen. We deduced the following, 
although highly speculative hypothesis illustrated in Figure 1. 
 
Our results indicated that strain 89V87 might activate plasminogen by direct contact. 
Thus, a possible hypothesis is that the PrV virion interacts with plasminogen, and 
directly converts plasminogen into plasmin. This would result in proteolytic plasmin 
activity in close proximity of the virus particle enabling virus passage through the 
basement membrane barrier. Further work will be necessary to unravel the exact 
mechanism of plasminogen activation by PrV.  
 
Figure 1. Hypothetical model for BM penetration of PrV via the plasminogen 
activator-plasmin system. A. Physiological situation- In the absence of specific stimuli, the 
extracellular matrix (ECM) remains intact. No uPA present in the cells. B. Situation of PrV 
infection- (1) For strains NS374 and 75V19, uPA generation may be stimulated, possibly via 
the viral serine/threonine protein kinase (PK) encoded by US3. Afterwards, activated uPA 
converts plasminogen into plasmin. As a result, plasmin takes part in extracellular matrix 
(ECM) degradation. (2) For strain 89V87, viral proteins may directly convert plasminogen 
into plasmin, thereby leading to ECM degradation.  





FeHV1 and CaHV1 cross the basement membrane in a plaque-wise manner similar to 
the mechanism previously described for PrV, BoHV1 and HSV.Our research revealed 
that the plasminogen activator-plasmin system plays an important role in the viral 
passage across the basement membrane. Based on this new information, a topical use 
of antiviral compounds such as plasmin inhibitor could be an interesting antiviral 
strategy. The current antiviral drugs that target viral DNA synthesis have been proven 
to be effective against herpesvirus infections. These drugs can inhibit virus replication 
and even suppress clinical manifestations but are not a cure for the disease. Different 
from these drugs, products like plasmin inhibitors may be effective during clinical 
episodes or used as preventive measures during exposure periods. 
 
Induction of virus-specific cellular and humoral immunity via vaccination is another 
antimicrobial (preventive) measure. If the hypothesis (Figure 1) mentioned above 
holds true for viral penetration of the BM, use of genetically modified viruses may 
elicit a robust adaptive immune response while preventing viruses from breaching the 
BM. Our research suggests that the established explant models can be effective tools 
to screen for genetically modified, live attenuated vaccines. 
 
Herpesviruses can cause co-infections with other viruses. In humans, epidemiological 
evidence between HSV and HIV infections has been documented (Wald and Corey, 
2007).  In HIV-infected patients, the uPA and uPAR expression are upregulated, and 
uPA/uPAR appear to be nonredundant signals counteracting virus invasion (Alfano et 
al., 2003). Similar to PrV, HSV infection may also activate the plasminogen 
activator-plasmin system, resulting in viral basement membrane penetration. It was 
reported that HSV1 enhances the generation of plasmin and plasmin enhances cell 
infection by HSV (Pryzdial et al., 2014). Based on these results reported, we speculate 
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that HIV might facilitate HSV replication and basement membrane penetration 
through plasminogen activator-plasmin system. This may explain why HSV infection 
is frequently associated with HIV acquisition. This valuable knowledge would 
contribute to the development of antiviral measures for HSV and HIV in humans in 
the future. 
 
The plasminogen activator-plasmin system plays a crucial role in hemostasis. HSV1 
envelope receptors exploit these proteases to enhance cellular infection by triggering 
host signaling mechanisms (Pryzdial et al., 2014). Some other enveloped viruses like 
influenza virus, SARS-CoV, may also use the system to affect hemostasis. As 
mentioned in 1.5.4, uPA activity increased in a dose-dependent manner following 
SARS-CoV infection (Gralinski et al., 2013). During influenza virus infection, 
plasminogen could contribute to the pathogenesis of the virus infection by promoting 
virus replication or by inducing a fibrinolysis-dependent harmful inflammatory 
response in the respiratory tract (Berri et al., 2013). It could be that these viruses have 
a similar mechanism to regulate some components expression/activation in the 
plasminogen activator/plasmin enzymatic cascade. The system may further 
demonstrate the delicate balance between virus invasion and ECM remodeling. 
Further work may concentrate on revealing the consistency mechanism of the above 
mentioned enveloped viruses. 
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Summary 
Different animal species host various alphaherpesviruses and may suffer from a 
diverse array of pathologies induced by these pathogens. During the primary infection 
of alphaherpesviruses, the host possesses several barriers that hamper invasion of 
pathogens. One essential barrier is the basement membrane (BM) underneath the 
epithelia. Previous studies in our laboratory have shown that alphaherpesviruses 
behave differently at the BM. The replication of equine herpesvirus 4 (EHV4) is 
restricted to the respiratory epithelium of the upper respiratory tract. Herpes simplex 
virus 1 (HSV1), suid herpesvirus 1 (PrV) and bovine herpesvirus 1 (BoHV1) 
penetrate through the BM, to reach and infect susceptible cells located in the 
underlying connective tissues. Equine herpesvirus 1 (EHV1) infects epithelial cells, 
but not underlying fibroblasts. Instead, it hijacks monocytes in the epithelium to cross 
the BM and invade its host. Feline herpesvirus 1 (FeHV1) and Canine herpesvirus 1 
(CaHV1), two important pathogens of cats and dogs, are not well studied. In the 
current thesis, we sought to establish models that allow the study of the mucosal 
invasion mechanism used by FeHV1 and CaHV1. In addition, since many 
alphaherpesviruses cause respiratory infections in their host, a better characterization 
of the pathogenesis of one of the infections may contribute to better insights in the 
pathogenesis of others.  
 
In Chapter 1, a general introduction of herpesviruses and an overview of the 
characteristics of ocular, respiratory and genital mucosae is provided.  
 
Subchapters 1.1-1.3 consist of a brief introduction of herpesvirus biology in general. 
Because the major focus in this thesis is on FeHV1, CaHV1 and PrV, more 
information is provided about the respective pathogenesis and symptomatology of 
these viruses.   
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Subchapter 1.4 mainly describes the structure and functions of the ocular surface, 
upper respiratory and lower genital tract tissues with emphasis on the basement 
membrane.  
Subchapter 1.5 focuses on the current knowledge of the plasminogen 
activator-plasminogen system.  
 
Chapter 2 formulates the aims of the thesis. 
 
In chapter 3, ex vivo models are described that allow to study feline herpesvirus 
replication in ocular and respiratory mucosae, which are represent the primary 
targets of infection. 
Feline herpesvirus 1 (FeHV1) is one of the major viral pathogens involved in 
rhinotracheitis and ocular disease in cats. Little is known about how the virus 
replicates in and invades the mucosae of the respiratory tract and eyes, resulting in 
lesions. In the present study, viral behavior during the early stage of infection was 
examined in the respiratory and ocular mucosae, the portals of entry of FeHV1 by 
using ex vivo explants. Three FeHV1 seronegative cats without ocular or respiratory 
problems were used in this study. Equal pieces (25mm2) of corneal, conjunctival and 
tracheal mucosa explants were maintained in an air-liquid culture at 37 °C and 5% 
CO2, and their viability was examined during 96 h of cultivation. All tracheal tissues 
were observed under a stereomicroscope for cilia beating, and only tracheal tissues in 
which cilia beating was present all over the explants were used. Corneal, conjunctival 
and tracheal explants were inoculated with the FeHV1 C-27 strain at 24 hours after 
cultivation and sampled at 0, 24, 48 and 72 hours post inoculation (hpi). Viral antigen 
positive cells were visualised via a direct immunofluorescence staining and series of 
stained cryosections were analysed with a Leica TCS SP2 confocal microscope. A 
quantitative morphological analysis of viral replication and invasion in the mucosae 
was performed by measuring plaque latitudes and penetration depths underneath the 
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basement membrane. The explants of three cats were maintained in an air-liquid 
culture up to 96 hours with a little decrease in tissue viability. After inoculation, 
FeHV1 was found to replicate in conjunctival and tracheal mucosae in a plaque wise 
manner but no infection was observed in corneal epithelium except for damaged sites. 
The plaques were observed from 24 hpi and plaque latitude increased over time. The 
viral plaque latitudes increased over time at a similar speed in trachea and conjunctiva. 
FeHV1 penetrated the BM in conjunctival and tracheal explants between 24 and 48 
hpi, and most plaques crossed the BM at 72 hpi. FeHV1 invaded the lamina propria 
more efficiently in tracheal tissues than in conjunctival tissues. In conclusion, the 
feline ocular and respiratory explants were suitable to study the early events of the 
pathogenesis of FeHV1 infections. Our study indicates that FeHV1 has a better 
capacity to invade the respiratory mucosa than the conjunctival mucosa, and prefers 
the conjunctiva but not the cornea as a portal of entry during ocular infection. 
 
Chapter 4 demonstrates CaHV1 respiratory and genital mucosal dissemination 
and invasion. 
The pathogenesis of canine herpesvirus 1 is not well characterized. We aimed to 
investigate the early steps in the pathogenesis of this pathogen known for its 
contribution to cases of respiratory and genital diseases. The replication kinetics and 
invasion characteristics of CaHV1 in tracheal and vaginal mucosae were compared 
using explants. The canine tracheal and vaginal mucosae explants were inoculated 
with CaHV1 F205 strain. The explants were collected at 0, 24, 48, and 72h pi, 
cryosections were made, fixed and stained for viral antigens by a double 
immunofluorescence labeling. A fluorescent terminal deoxynucleotidyl transferase 
mediated dUTP nick end labeling (TUNEL) staining was used to analyze the viability 
of the canine tracheal and vaginal mucosal explants. The explant models were 
maintained up to 96h without significant changes in cell viability. Both explants were 
successfully infected with CaHV1. The virus spread in a plaque wise manner, as 
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shown by immunofluorescence analysis. Upon inoculation, the plaques were already 
observed at 24 hpi, their size increased over time. CaHV1 started to penetrate the BM 
only after 48 hpi in tracheal explants but already after 24 hpi in vaginal explants. The 
plaque penetration depth increased over time and was larger in vaginal mucosa 
explants compared to tracheal mucosa explants. The canine respiratory and genital 
explants were established in this study, enabling research on CaHV1 replication and 
invasion in the mucosae. CaHV1 showed a better capacity to replicate and invade 
vaginal mucosa compared to tracheal mucosa, based on both the latitude and 
penetration depth of the plaques of viral antigen positive cells. 
According to our findings in the former two chapters, both FeHV1 and CaHV1 are 
able to penetrate the basement membrane in a plaquewise manner, which is similar to 
what was previously observed for pseudorabies virus (PrV). Therefore, we were 
interested in which viral effectors are required for the viral invasion mechanism of 
this group of alphaherpesvirus and used the established model of PrV on respiratory 
mucosa for investigation.   
 
Chapter 5 shows pseudorabies virus invasion through the basement membrane 
barrier occurs via activation of the uPA-plasmin system.  
Previous studies showed that a trypsin-like serine protease is involved in pseudorabies 
virus (PrV) invasion through the basement membrane barrier of porcine nasal 
respiratory mucosa and it was hypothesized that this serine protease might be uPA, 
which can convert plasminogen into active plasmin. Different strains of PrV, namely 
89V87, 75V19 and NS374, were tested in this experiment. In a first step, porcine 
respiratory explants were infected with PrV. As demonstrated by Western blot, 
various forms of plasminogen and plasmin were found in non-infected and 
virus-infected porcine respiratory explants. As demonstrated by IF staining, plasmin 
was expressed in the virus plaque starting from 24 hours post inoculation (hpi) in 
porcine respiratory explants. In a second step, a detailed quantitative analysis system 
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was used to determine the kinetics of horizontal and vertical virus spread in nasal 
explants, in the presence or absence of WX-340 (an uPA inhibitor) and tranexamic 
acid (an plasmin inhibitor). Plaque latitudes and penetration depths underneath the 
basement membrane were determined at 24h post inoculation (pi). Basement 
membrane penetration of two older PrV strains, NS37 and 75V19, were blocked by 
both the uPA inhibitor and the plasmin inhibitor, while basement membrane passage 
of the more recent strain 89V87 was only blocked by the plasmin inhibitor.  
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Samenvatting 
 
Alfaherpesvirussen worden teruggevonden bij verscheidene diersoorten en kunnen 
een divers spectrum aan ziektebeelden induceren. Gedurende de primaire infectie 
worden deze pathogenen geconfronteerd met verschillende barrières binnen de 
gastheer, die de invasie trachten te verhinderen. De basale membraan (BM) onder het 
epitheel vormt een dergelijk belangrijke barrière. Voorgaande studies binnen ons 
laboratorium hebben aangetoond dat elk alfavirus zich anders gedraagt ter hoogte van 
de BM. Bijvoorbeeld, de replicatie van het equiene herpesvirus 4 (EHV-4) beperkt 
zich tot het respiratoire, mucosale epitheel van de bovenste luchtwegen. Herpes 
simplex virus 1 (HSV-1), suid herpesvirus 1 (of pseudorabiës virus, PrV) en boviene 
herpesvirus 1 (BoHV-1) zullen na primaire infectie ter hoogte van de mucosa de BM 
doorboren om zo de gevoelige target cellen in het onderliggende bindweefsel te 
bereiken. Het equiene herpesvirus 1 (EHV-1) daarentegen infecteert de mucosale 
epitheelcellen maar niet de onderliggende fibroblasten. Als gevolg, maakt EHV-1 
gebruik van een alternatief mechanisme om de BM te doorkruisen. EHV-1 zal typisch 
de aanwezige monocyten in het epitheel ‘hijacken’ om de BM te doorboren en zo zijn 
gastheer te invaderen. Het feliene herpesvirus 1 (FeHV-1) en caniene herpesvirus 1 
(CaHV-1) zijn twee belangrijke pathogenen van de kat en hond maar werden tot op 
heden onvoldoende bestudeerd. In de huidige thesis werd er dan ook getracht 
modellen op te stellen die de studie van de mucosale invasiemechanismen van zowel 
FeHV-1 als CaHV-1, zal toelaten. Aangezien vele alfaherpesvirussen respiratoire 
infecties veroorzaken in hun gastheer, zal de karakterisatie van de 
invasiemechanismen van deze twee alfaherpesvirussen bijdragen tot betere inzichten 
in de pathogenese van andere alfaherpesvirussen.  
 
In hoofdstuk 1, werd een algemene introductie gegeven over herpesvirussen 
evenals een beschrijving van de eigenschappen van de oculaire, respiratoire en 
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genitale mucosa. In tussenhoofdstuk 1.1 tot 1.3 kwam de algemene biologie van 
herpesvirussen aan bod. Aangezien er binnen deze thesis wordt toegespitst op FeHV-1, 
CaHV-1 en PrV, werd de pathogenese en symptomatologie van deze virussen in meer 
detail weer gegeven. In tussenhoofdstuk 1.4 werd een overzicht gegeven van de 
structuur en functie van de oogweefsels, de bovenste luchtwegen en de lagere genitale 
weefsels waarbij extra aandacht besteed werd aan de BM. In tussenhoofdstuk 1.5 
wordt de huidige kennis van het ‘plasminogeen activator-systeem’ beschreven. 
 
In hoofdstuk 2, werden de doelstellingen van deze thesis uiteengezet. 
 
In hoofdstuk 3, werden ex vivo modellen beschreven die ons toelaten de replicatie 
van feliene herpesvirussen in de oculaire en respiratoire mucosa, de primaire 
plaats van infectie, te bestuderen. FeHV-1 is één van de voornaamste virale 
oorzaken van rhinotracheitis en oculaire infecties bij de kat. Er is weinig geweten over 
de replicatie van dit virus en hoe deze de oculaire en respiratoire mucosa binnendringt 
om zo aanleiding te geven tot lesies. In de huidige studie werd gebruik gemaakt van 
ex vivo explantmodellen om de vroege stadia van infectie ter hoogte van de 
toegangspoorten voor FeHV-1, met name de respiratoire en oculaire mucosa, te 
bestuderen. Drie FeHV-1-seronegatieve katten zonder oculaire of respiratoire 
symptomen werden geïncludeerd in deze studie. Uniforme explanten (25mm2) van de 
cornea, conjunctiva en trachea werden gecultiveerd als een “air-liquid interface 
culture” bij 37 °C en 5% CO2 en de vitaliteit werd gecontroleerd na 96 uur in cultuur. 
Verder werd ook de activiteit van de cilia nagegaan voor alle trachea explanten via 
stereomicroscopie en enkel de explanten waarbij ciliabeweging werd waargenomen 
over de gehele explant werden gebruikt in verdere experimenten. De explanten van de 
cornea, conjunctiva en trachea werden geïnoculeerd met FeHV-1 stam C-27. Op 
specifieke tijdstippen (0, 24, 48 en 72 uur) post inoculatie (p.i.) werden cryosecties 
gemaakt en deze ondergingen vervolgens directe immunofluorescentiekleuring. Deze 
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kleuring werd dan gevisualiseerd met de Leica TCS SP2 confocale microscoop en het 
aantal positieve cellen werd bepaald. Een kwantitatieve, morfologische analyse van de 
virusreplicatie en mucosale invasie gebeurde via het opmeten van de plaquelatitude en 
penetratiediepte onder de BM. Explanten van drie katten konden gecultiveerd worden 
als een ‘air-liquid interface culture” gedurende 96 uur met een beperkt verlies aan 
explant vitaliteit. Na inoculatie met FeHV-1, kon plaquegewijze virusreplicatie 
geobserveerd worden in de mucosa van de conjunctiva en trachea. In het corneale 
epitheel kon echter geen infectie waargenomen worden met als uitzondering ter 
hoogte van beschadigde sites. Plaques werden typisch geïnduceerd vanaf 24 uur p.i. 
en de plaquelatitude nam progressief toe met de tijd. Deze toename gebeurde met 
eenzelfde snelheid in zowel de trachea als de conjunctiva explanten. FeHV-1 
doorboorde de BM van de conjunctiva en trachea explanten tussen 24 uur en 48 uur 
p.i. waarbij de meeste plaques de BM doordrongen bij 72 uur p.i. De invasie van de 
lamina propria gebeurde op een veel efficiëntere manier in de trachea explanten in 
vergelijking met de conjunctiva explanten. Deze bevindingen leiden tot de conclusie 
dat de feliene oculaire en respiratoire explanten uiterst geschikt zijn om de initiële 
infectiestadia gedurende FeHV-1 infectie te bestuderen. Met deze studie konden we 
eveneens aantonen dat FeHV-1 met grotere efficiëntie de respiratoire mucosa 
invadeert (in vergelijking met de mucosa van de conjunctiva) en dat deze een 
voorkeur heeft voor de conjunctiva maar niet de cornea als predominante 
toegangspoort gedurende oculaire infecties bij de kat.  
 
In hoofdstuk 4, werd de invasie en disseminatie van CaHV-1 in de respiratoire en 
genitale mucosa aangetoond. De pathogenese van het CaHV-1 is slechts in beperkte 
mate gekarakteriseerd. Het doel van deze studie was dan ook om de vroege 
replicatiestadia van CaHV-1, het causatief agens van respiratoire en genitale 
aandoeningen bij de hond, verder uit te klaren. Hiervoor werd allereerst de 
replicatiekinetiek en het invasiemechanisme van CaHV-1 in de mucosa van de trachea 
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en vagina met elkaar vergeleken door opnieuw gebruik te maken van explantmodellen. 
Tracheale en vaginale mucosa explanten van de hond werden geïnoculeerd met 
CaHV-1 stam F205. Op specifieke tijdstippen p.i. (0, 24, 48 en 72 uur) werden de 
explanten ingevrozen om cryosecties te maken. Deze cryosecties werden nadien 
gefixeerd en gekleurd voor virale antigenen via dubbele immunofluorescentielabeling. 
De “Terminal deoxynucleotidyl transferase dUTP Nickend Labeling” of 
TUNEL-kleuring werd gebruikt om de vitaliteit van de caniene trachea en vagina 
explanten na te gaan. Beide explantmodellen konden in cultuur gehouden worden tot 
96 uur zonder de vitaliteit significant te beïnvloeden. De trachea en vagina explanten 
werden vervolgens geïnfecteerd met CaHV-1 en via immunofluorescentie analyse 
werd er aangetoond dat dit virus zich verspreid in een plaquegewijze manier. Na 
inoculatie konden plaques waargenomen worden op 24 uur p.i. en de grootte van deze 
plaques nam toe met de tijd. In het trachea explantmodel, penetreerde CaHV-1 de BM 
pas op 48 uur p.i. In tegenstelling tot de penetratie in de trachea explanten, werd in de 
vagina explanten reeds op 24 h p.i. penetratie van de BM waargenomen. De 
plaquediepte nam in beide modellen toe met de tijd en was typisch hoger in vaginale 
mucosa explanten in vergelijking met tracheale mucosa explanten. Samengevat 
werden in deze studie twee explantmodellen, een respiratoir en genitaal explant model, 
tot stand gebracht die ons toelaten de replicatie en invasiemechanismen van CaHV-1 
in de mucosa te bestuderen. Op basis van de waargenomen latitude en penetratiediepte 
van de plaques in cellen positief voor virale antigenen konden we besluiten dat 
CaHV-1 een hogere capaciteit heeft om te repliceren en door te dringen in de vaginale 
mucosa in vergelijking met de tracheale mucosa. In overeenkomst met onze 
bevindingen in de twee voorgaande hoofdstukken, kunnen we concluderen dat 
FeHV-1 en CaHV-1 beiden de basale membraan kunnen penetreren door middel van 
plaques, op een gelijkaardige wijze als geobserveerd voor het pseudorabies virus 
(PrV). Om in een volgende stap de virale effectors die essentieel zijn tijdens het 
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invasieproces van deze alfaherpesvirussen te achterhalen, werd dan ook gebruik 
gemaakt van het PrV infectiemodel in de respiratoire mucosa.  
 
In hoofdstuk 5, werd gedemonstreerd dat PrV invasie van de BM gebeurt via 
activatie van het uPA-plasmine systeem. Vorige studies hebben aangetoond dat een 
trypsine-like serine protease een rol speelt in de invasie van PrV doorheen de BM van 
de porciene nasale respiratoire mucosa. Volgens onze hypothese is dit serine protease 
een urokinase-type plasminogeen activator enzym, dat plasminogeen omzet naar het 
actieve plasmine protease. Verschillende stammen van PrV (89V87, 75V19 en N374) 
werden getest in dit experiment. Allereerst, werden porciene respiratoire mucosa 
explanten geïnfecteerd met PrV. Verschillende vormen van plasminogeen en plasmine 
werden terug gevonden in zowel niet-geïnfecteerde als virus-geïnfecteerde explanten 
na western blot analyse. In de respiratoire explantmodellen werd plasmine expressie 
in de virus plaques waargenomen op 24 uur p.i. Verder werd een detailleerde, 
kwantitatieve analyse uitgevoerd om de kinetiek van zowel horizontale als verticale 
virusspreiding in nasale explanten in de aan- of afwezigheid WX-340 (een uPA 
inhibitor) en tranexamic zuur (een plasmine inhibitor) te bepalen. Plaquelatitude en 
penetratiediepte onder de BM werden bepaald op 24 uur p.i. De BM penetratie van 
twee oudere PrV stammen, NS37 en 75V19, werd geïnhibeerd door zowel de uPA 
inhibitor als de plasmine inhibitor. De BM penetratie van de meer recentere PrV stam, 
89V87 daarentegen werd enkel geïnhibeerd door de plasmine inhibitor.  
 
In hoofdstuk 6, werd alle bekomen data geëvalueerd en kritisch besproken.   
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